introvivo reduces the amount of the virus that causes hepatitis c infection . incivo is used for the treatment of adults , adolescents and children from the age of 18 years with peginterferon alfa , ribavirin and telaprevir . it belongs to a class of medicines called ns3 - 4a protease inhibitors . it works by blocking the ntr4a enzyme , which is essential for hepatitis c virus to multiply . it can also be used in patients who have previously been treated with an interferon - based regimen .
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo if you : - are taking peginterferon alfa or ribavirin . your doctor may need to adjust the dose of incivo or their contraindications ( e . g . pregnancy precautions ). incivo should not be used in patients who are unable to tolerate the effects of the medicine alfuzosin ( see " other medicines and incivo "). - have symptoms
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg , 6 mg , 2 mg , 8 mg or 6 mg twice a day . if you have both hepatitis c virus infection and human immunodeficiency virus infection , your doctor may prescribe efavirenz ( the same dose as for incivo ). the recommended dosage regimen , 3 mg and 8 mg , is based on how well your body is responding to incivo . use in children and adolescents the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may spread to other areas of your body . other symptoms of a severe skin reaction tell your doctor or nurse immediately if you develop a skin rash . your doctor may decide to treat your rash with other treatments . a rash may be accompanied by fever , tiredness , swelling of the face or swelling of lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms , painful skin blisters or bl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special temperature storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture .
what incivo contains the active substance in incivo is telaprevir . each tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose ( e460 ), silica colloidalanhydrous , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack film - coated , yellow caplet - shaped tablets are
the active substance of zinbryta is daclizumab beta , a monoclonal antibody ( a type of protein that recognises and attaches to a specific target substance in the body ). what you need to know before you start to use this medicine , tell your doctor or pharmacist if you have any questions about how zinbaryta works or why this medicine has been prescribed for you . what is multiple sclerosis ? ms is usually treated with therapy consisting of two ms treatment followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ).
you must not be given zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have liver problems . this medicine is not recommended for you . you have or have had any other autoimmune disorders . you are taking any other medicines , including herbal supplements . this is because these may increase the risk of liver side effects . your doctor may need to adjust your dose of these medicines while you are being given z
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how and when to inject your first dose your doctor may decide to increase your dose to a maximum of 40 mg twice a day depending on the results of this blood test . you will also have a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor or pharmacist straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( might affect up to 1 in 100 people ): severe inflammation of the liver may lead to death
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you need to use a new syringe / pen , or a refrigerator , please record the date on the label of the pen when it is first removed from the refrigerator , and the date after which it should be discarded . the following information is intended for
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms ( 23 mg ) of dacluzumabbeta . 1 ml solution for injection ( injection ) for injection provides a clear , colourless solution to deliver a dose that is suitable for the treatment of children and adolescents . - the other ingredients are : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) and water for injections ( see section 2 under ' important information about some of the ingredients of zin bryta ').
what wilzin is wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . how wilzin works wilzin attaches to copper in the intestine and blocks its further accumulation in the body . this results in an increase in the amount of copper produced by the liver , which can be harmful to the cells of the brain . as a result of this treatment , wilzin may not work as well as it should .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents . your doctor will monitor your symptoms closely during the treatment . blood and urine will be tested to ensure that sufficient
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens should be taken with or without food . the usual starting dose is 25 mg or 50 mg once a day . your doctor will tell you how many capsules of wilzin to take and how long you should continue to take them . the dose may be increased or decreased depending on how you respond to the medicine . for example , if you weigh 50 kg or more , your doctor may increase your dose to a maximum of 1 mg wilzin twice a day ( morning and evening ). for
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 1 , 000 ) very small number of patients are known to have gastric irritation after treatment . changes in blood tests there may be an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects if you
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ). each 50 mg capsule contains 20mg of zinc , equivalent to 167 . 84 mg zincacetate diydrate . - the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e110 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are printed with " wilzin 50 mg " on one side and plain on the other . the printing
biktarvy contains the active substance bictegravir , which is an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active ingredient is emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antirubiciral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) in adults , adolescents and children aged 1
do not take biktarvy if : you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking bikarvy : if you have or have ever had liver problems .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : antacids to prevent stomach ulcers , heartburn and acid reflux , aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " important information about these medicines "). biktarvy can be taken with or without food . talk to your doctor if you have any further questions on the use of this medicine . your doctor may ask you to take other medicines while you are on dialysis . see section " other medicines and bik
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur soon after hiv treatment is started . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that may have no obvious symptoms . autoimmune disorders ( when the immune system attacks the body tissue ) can occur many months after you start treatment . if you have any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg film - coated tablet ( tablet core microcrystalline cellulose , croscarmellose sodium and magnesium stearate ). - the other ingredients are film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , talc , iron oxide red ( e172 ) and iron oxide black ( e 172 ). what biztarvy looks like and contents of the pack b
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your body . the insulin that your body makes does not work as well as it should . novonorm helps control the level of sugar produced in your blood when you have type 2abetes . treatment is usually started by diet and exercise and weight reduction . your doctor will work out how much insulin you need and how often you need to take it .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 you have liver problems . your doctor may need to adjust your dose of no
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take the tablet at about the same time each day . do not exceed the recommended daily dose of 30 mg . your doctor may increase your dose by 4 mg to 30 mg every 16 hours , depending on how you respond to the change in your blood sugar . this may be a hypo . if you take more no
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of novonorm ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , see " warnings and precautions " below . if you experience symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating , this may be a sign of anaphylactic reaction . other side effects are listed below : very common ( may affects more than 1 user in 10 ) - stomach pain - diarrhoea rare ( likely to affect 1 to
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ). 1 mg tablet contains iron oxide red ( e 172 ) and 2 mg tablets contain iron oxide black ( e 132 ) and are available in blister pack sizes of 30 , 90 , 120 or 270 tablets . not all pack sizes may be marketed .
pumarix is a vaccine used in adults ( from 18 years of age ) to prevent pandemic flu ( influenza ). it is a type of influenza that happens at intervals not known ( cannot be estimated from the available data ). it spreads rapidly around the world . it may affect up to 10 in 100 people . this is a very rapid change in the way things happen . pandemic influenza is similar to ordinary flu . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu
pumarix should not be given : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse immediately . the vaccine may not fully protect all persons who are vaccinated . medical treatment may be needed in case of an
pumarix is recommended for use in adults 18 years of age and older . pumarix contains a similar h5n1 as03 to those found in the blood . children and adolescents there is no information available on the use in children or adolescents under the age of 18 years . there is limited information on the safety and efficacy of the vaccine in this age group . the recommended dose is one dose ( 0 . 5 ml ) for children from 3 - 9 months of age , followed by a dose ( 1 ml ) in adolescents from 10 - 17 months . your doctor or nurse will give you the full dose of pumar
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure and shock . your doctor may need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( likely to affect up to 1 in every 10 people ) redness or swelling at the site of the injection fever sweating shivering diarrhoea feeling sick uncommon ( unlikely to affect 1 in 100 people ) bruising a hard lump or itching warmth swollen
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the sachet in order to protect from light . after preparation of the suspension , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 30 .
what pumarix contains - the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . - the other ingredient is haemagglutinin , which is produced by recombinant dna technology ( rdna technology ). in the pandemic , the vaccine contains an ' adjuvant ' as03 , which reduces the amount of dl - α - tocopherol and polysorbate 80 ( adjuvants ). the other ingredients of the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate ,
somakit t is a radiopharmaceutical product containing an active substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active substance in somakit to be used for this procedure is called epidermal growth factor receptor ( egfr ). it is used when the amount of gallium in your body cannot be adequately estimated from the available data . your doctor will perform a medical imaging procedure called positron emission tomography ( ptom ) on your pet . this medical procedure is to obtain images of the abnormal cells and tumours in your disease . somak
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have experienced any kind of allergic reaction ( see section 4 for more information ). if you think any of these apply to you , tell your doctor straight away . children and adolescents do not give this medicine to children or adolescents below the age of 18 years because of the risk of dehydration . the examination will be repeated every 28 days . there are others medical conditions that affect the way the
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . 29 the nuclear medicine doctor supervising the procedure will decide the quantity of somakttoc to be administered . the usual dose is between 100 mg and 200 mg megabecquerel per kilogram of body weight each day . the dose may be increased or decreased depending on your response to somak
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : allergic reactions ( hypersensitivity ) somakit t may cause symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : somakit t will be stored in a refrigerator ( 2 - 8 ). storage at room temperature ( up to 25 ) does not result in any visible signs of deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - the solution contains hydrochloric acid which is used to adjust the amount of radioactivity in the blood when radiopharmaceutical preparation is performed . - a glass vial with black flip - off cap contains a white powder , and the contents of a
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women . it belongs to a group of non - steroidal aromatase inhibitors , which are used to keep the disease under control . it is used in combination with a medicine called exemestane ( a steroid aromatase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels , lung or pancreas
always take afinitor exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you if you need to change your dose of cancer treatment . do not take more than the recommended dose . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor if you have ever taken everolimus , sirolimus , temsurolimus or any of the other ingredients of this medicine ( listed in section 6 ). if any of these apply to you , tell your doctor , pharmacist or nurse before taking af
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is one 10 mg tablet once a day . if you take more afinitor than you should if you have liver problems , your doctor may prescribe a lower dose of Afinitor ( between 5 mg and 5 mg ) or a higher dose of 7 . 5 mg depending on the severity of certain side effects . your doctor will tell you how many tablets you need to take . you should continue to take afininitor until your doctor tells you otherwise . stopping treatment with afin
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if any of these occur , stop taking the medicine and seek medical advice straight away . the following side effects have been reported with the combined use of fentanyl : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ) fever , coughing , difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and on the carton after exp . store below 25 . store in the original package in order to protect from moisture . open the blister only directly prior to intake . the tablets can be taken with or without food . this medicine does not require any special temperature storage conditions , and should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . each tablet contains either two or three active substances . - the other ingredient is tablet core : alfentanil . one tablet contains 2 . 5 mg or two of the active substances , respectively , of which two may be present at the same time . two tablets contain 5 mg , two of them might be present in the morning and one of the other active substances may be presented in the evening as an off - white to slightly yellowish tablets . the other ingredients are : tablet coating : hypromellose , crospovidone , lactose
what laventair ellipta is the active substance in this inhaler is umeclidinium bromide ( also called vilanterol ). this belongs to a group of medicines called bronchodilators . what it is used for and why it is important to use it your doctor has prescribed this medicine for you because of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have asthma . this medicine should not be used in patients with asthma . your doctor should tell you if you have heart problems or high blood pressure . you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). you have epilepsy or thyroid gland
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . do not use more than your doctor tells you to use . if you use more laventair ellipta than you should contact your doctor , pharmacist or nurse immediately if you have any of the following symptoms : a sudden attack of breathlessness or wheezing . to control this attack you may use a quick - acting reliever inhaler ( such as sal
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect upto 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you experience immediate
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose of 55 micrograms ( 0 . 5 millilitres ) of the two active substances , respectively . each delivered dose ( the dose that leaves the mouthpiece ) contains either a sufficient dose to reach a maximum dose of 70 mbq ( 1 . 5 million iu ), or a sufficient amount to reach the maximum dose ( 2 . 0 milligrams ). - the other ingredients ( excipients ) are : tablet core : lactose '
the active substance of tremfya is guselkumab , which is a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis in adults and children . it is used in adults with moderate to severe " plaque psORiasis " which is an inflammatory condition that affects the skin and nails . it can improve the condition , the appearance of nails , and reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya : if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had an active infection or active tuberculosis warnings , precautions , or if you have been in close contact with someone who has or has had an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening condition in which patients 36 have an infection and symptoms of an infection
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is injected under the skin ( subcutaneous injection ) over a period of 4 to 8 hours . the recommended dose is one injection once a day . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains large particles . if the product is damaged or shows signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what tremfya contains - the active substance is guselkumab . one ml of each pre - filled syringe contains 100 mg of gusel kumab in 1 ml of solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfa looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfa is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1
the active substance of trepulmix , treprostinil , belongs to a group of medicines called prostacyclins , a hormone produced by the body that lowers blood pressure by relaxing blood vessels , thus preventing them from clotting . the active substance in this medicine is treprospulmix . it is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients whose condition is persistent or recurrentcteph . it can be treated with surgical treatment , or with exercise capacity . symptoms of the disease can vary from patient to patient , but the most common ones
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease which causes the blood vessels in the lungs to become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have a heart problem . have had a heart attack ( myocardial infarction )
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( injection under the skin ) into a small tube ( cannula ) in the abdomen or thigh . your doctor will show you how to use it . you will be instructed how to prepare and give it to you by a doctor or nurse . it is recommended that you use a portable pump to pump your treprostinil through the pump into the infusion line to prevent accidental overdose . the recommended dose is 1 to 2 . 5
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction . this may be the case for a small number of people . tell your doctor straight away if you notice any of the following : signs of a possible infusion site bleeding , bruising or at the site of the infusion : headaches , nausea , diarrhoea jaw pain common : dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted product should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 30 days at 2 - 8 unless continuous subcutaneous infusion is carried out in a single reserve ( syringe ) of undiluted trepulmix
what trepulmix contains - the active substance is treprostinil ( as sodium ). one vial contains 1 ml of solution for injection ( 1 mg / ml ). - the other ingredients are : 1 ml : pregelatinised sodium salt 10 micrograms / ml ( 10 microlitres ) treprosteinil and sodium salt . one ampoule ( 1 . 5 ml ) contains 2 . 5 milligrams of solution ( 1mg / ml ) trepristinill ( asodium salt ). each 10 milligram ( 0 . 25 millilitres ) contains 25 mg of tre
the active substance of thorinane is enoxaparin sodium . it belongs to a group of substances called low molecular weight heparin ( lmwh ). the two active ingredients in the medicine are : thorcinane is used to : 1 : prevent existing blood clots from forming ( see section 2 ' how to treat your blood ') and to : 2 : prevent and / or reduce the risk of stopping blood clotts from forming in your blood . your doctor will test your blood before , during and after an operation if you have an acute illness ( unstable angina ) if your heart is not working properly if
do not use thorinane : - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to any of these , including a severe drop in the number of your clotting cells ( platelets ). if
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . if the bleeding is severe or if you experience any bleeding event that does not stop immediately ( exceptional weakness , tiredness , paleness , dizziness , headache ), or unexplained swelling , stop taking your medicine and contact your doctor immediately . your doctor may decide to temporarily or permanently stop your medicine . if you are not sure , talk to your doctor , pharmacist or nurse before taking the medicine . tell your doctor straight away if you have : a severe allergic reaction , difficulty breathing , swelling of the lips , mouth , throat or eyes (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 . after dilution the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2ºc - 8ºc . this medicine is for single use only . the thorinane pre - filled syringes should be disposed of in accordance with local requirements .
what thorinane contains - the active substance is enoxaparin sodium . each pre - filled syringe contains 100 micrograms ( 0 . 2 milligrams ) of an active substance . one vial of 2 , 000 microlitres contains 2 , 500 microgram s ( 1 milligram ) of enoxparin sodium ( as monotherapy ). - the other ingredients are water for injections ( see section 2 under " thorinicane contains sodium "). what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle
senstend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , helping to control the rate of ejaculation .
do not use senstend : - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if you have a history of allergy or sensitivity to local anaesthetics ( e . g . amide - type local anaesthesia ), a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) or anaemia ( methaemoglobinaemia ). medicine sensitivities and sensitivity can be serious and can lead to severe liver problems
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 1 spray in each head of your penis ) every 3 hours for 24 hours . use in children and adolescents the recommended starting dose is 4 sprays per day . use the spray container at the same time each day . the pumpchanism involves the valve to avoid contact with eyes , nose , mouth and ears . after using the pump , 1 spray into the foreskin of your head , inside your penis
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with senstend : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( might affect up to 1 in 100 people ) headache local irritation of the throat or irritation in the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in or around the penis pain or discomfort in or near the penis itching in and near the anus rectum loss of feeling in and around the mouth difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the metal container after exp . this medicinal product does not require any special storage conditions . after first opening , the product should be used immediately . however , if not used immediately , storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . if you use more senstend than you should if you have
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms lidocain ( equivalent to 50 microlitres ). - the other ingredients are propanedorphine 50 mg : each spray delivers a dose of 7 . 5 microgram ( 0 . 25 millilitres ) lidocane and 2 . 5 milligrams ( 1 . 75 millilitre ) prilucaine . - each spray container contains 6 . 5 ml solution . - the solution is clear to opalescent and colourless to pale yellow . - after reconstitution
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with an autologous stem - cell transplant or with a transplant . advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) a medicine called nivolumab , which is a monoclonal
do not take opdivo : - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given opsdivo if : - you have problems with your heart such as a change in the rhythm of the heartbeat or an abnormal heart rhythm . - your lungs have breathing difficulties or cough . this may be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ) or diarrhoea ( watery , loose or soft stools ). if you have any symptoms of inflammation
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose for adults is one tablet ( 240 mg ) once a day ( 2 tablets of 480 mg ) for 4 weeks . your doctor will prescribe the strength that is right for you . if you cannot take ipilimumab as prescribed by your doctor , the treatment will be stopped . for the treatment of skin cancer , your doctor may prescribe a different dose ( 1 mg ) of nivolumab per kilogram of your body weight , which will be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours after preparation . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg ( as 240 mg ) of solution for injection . - the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 under ' important information about sodium '). - the solvent is mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections
clopidogrel tad contains the active substance dicagrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products help to reduce the chances of blood clots forming ( a process that can lead to a rare , but potentially life - threatening , occurrence of bloodclots , including thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrom
do not take clopidogrel tad : if you are more than 30 years of age . if you think you may be allergic , or if you have been told by your doctor that you have a medical condition that is currently causing bleeding ( such as a stomach ulcer or bleeding within the brain ). if you suffer from severe liver disease . if any of the above applies to you , or you are not sure , talk to your doctor or pharmacist before taking the tablet . warnings and precautions before you take the tablet , you should tell your doctor if : you have any other risk of bleeding such as - a medical
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a different dose . the usual starting dose , which is one 300 mg tablet each day , is one half a milliliter of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel tad contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core ; tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ]) in the film coating ; tablet coat : talc and mac
tacforius contains the active substance tacrolimus , which is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius is used to prevent rejection of transplanted organs by the liver , kidney and heart after any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , any macrolide , antibiotic ( e . g . erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment , if you : - have previously had a prolonged - release capsule . - have ever had a long - release . - are not able to keep the capsule tightly closed in order to protect from moisture
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor who is experienced in the use of this medicine . transplant patients should take the same tacrolimus medicine as adults . however , if you have had a transplant , your doctor may prescribe you a higher or lower dose . your doctor will tell you how many capsules to take . if you take more tacforius than you should if you accidentally take too many capsules , talk to a doctor or go to a hospital straight away . take the medicine pack with you
like all medicines , this medicine can cause side effects , although not everybody gets them . infections tell your doctor or nurse straight away if you notice any of the following serious or potentially life - threatening infections while you are being treated with tacforius : severe effects of allergic and anaphylactic reactions ( benign or malignant tumours ) which have been reported in patients who were treated in the post - marketing phase or during the post marketing phase ( see section " warnings and precautions "). these may be signs of a very severe reduction in red blood cell counts ( agranulocytosis ), a severely lowered number of white
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after first opening the aluminium wrapping , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains - the active substance is tacrolimus . each capsule contains 0 . 5 mg . each prolonged - release hard capsule contains a total of 1 mg of tacrolamus ( as monohydrate ). each capsule is available in a pack containing 1 hard capsule and 1 soft capsule . the other ingredients are capsule content hypromellose ( 2910 ), ethylcellulose ( e463 ), lactose , magnesium stearate ( e470b ( e572 ) ( see end of this leaflet ). capsule shell tacforius 1 mg and 3 mg capsule shell : red iron oxide (
clopidogrel zentiva is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the time it takes for this clumping to stop , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process known as thromboembosis ). clopidoggingrelzentiva helps to prevent bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), a process called atherothromb
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are in any doubt at all ), tell your doctor or pharmacist . warnings and precautions it is important that you and your doctor know what you are taking and what precautions you need to take to avoid the effects of cl
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower dose , such as one 300 mg tablet once a day , until your doctor tells you otherwise . then , the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . clopidogrel zentiva is for single use only . aluminium blisters : do not store above 30 . store in the original package in order to protect from moisture . bottle : keep the bottle tightly closed . chemical and physical in - use stability has been demonstrated for seven days at 25ºc to 30ºc . after first opening of the bottle the product should be used immediately
what clopidogrel zentiva contains the active substance is clopidoogrel . each tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients ( excipients ) are ( see end of section 2 ' take the tablet with lactose ') - tablet core : hydrogenated castor oil ( e1203 ), mannitol ( e421 ) ( e468 ) ( partially hydrolysed ) ( in the tablet core ) - tablet coating : microcrystalline cellulose ( e460 ), macrogol 6000 ( e1521 ), low - substituted hydro
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . it must be used immediately after dilution with another medicine . tiny radiation doses are used for the treatment of radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . - the following information is intended for the medical or healthcare professionals only . - you must not receive the medicine as it contains a radioactive medicine or another medicinal product . - there are strict laws on the use , handling and disposal of radiopharmaceuticals .
your doctor will supervise the treatment . method of administration yttriga is for radiolabelling of medicinal products for specific diseases . your doctor will decide on the appropriate dose for you . the treatment will be supervised by a healthcare professional who is experienced in the care of patients with a history of overdose and who will provide appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances are in place to protect the environment . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). each vial contains a v - capped bottom . the vial is a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . the active substance in ciambra , cisplatin , is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in adults who have not received prior chemotherapy . in patients who have had at least one prior treatment for lung cancer , the active ingredient of ciambine ( called " mesodysplatin ") is used as part of the initial treatment . if you have lung cancer that has spread to your other organs , ciam
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before breast - feeding . before starting treatment , you should tell your doctor if you have recently received or are about to receive a vaccine against yellow fever . your doctor may decide to delay or discontinue the use of the product unless you have discussed this with your doctor . if you think you may be at an increased risk of having problems with your kidneys , your doctor will give you ciam
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of the body . your doctor will work out this body surface area based on your weight and your response to treatment . this will depend on your blood cell counts and on your general condition . a hospital pharmacist or nurse will have mixed the cimbra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . the infusion will last approximately 10 minutes . if you are given more ciam
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience fever or infection ( with a temperature of 38ºc or greater ), sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you have chest pain ( with or without a fast heart rate ), pain , redness , swelling or sores in your mouth ( signs of allergic reaction ). if you develop skin rash ( often with burning or prickling sensation ) or fever (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special temperature storage conditions . the infusion solution of pemetrexed should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 , but may be up to 15 days at 25 . the reconstituted solution must be used within 24 hours of preparation . the
what ciambra contains - the active substance is pemetrexed . each vial of piambra 100 iu / ml solution for infusion contains 100 milligrams ( millilitres ) of pemrexed ( as pemphrexed disodium hemipentahydrate ). each single - use vial ( 500 iu ) contains 500 milligram ( milliliter ) of the other ingredients ( excipients ). - further dilution by a healthcare professional is required prior to administration . - after reconstitution , the solution contains 25 mg / ml ( 0 . 25 %) of
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to treat certain infections in your blood . immunogam can be used in adults to prevent increased levels of human hepatitis b immunoglubulins , such as immunoglobinulin g ( ig ) in the blood plasma of screened adults . your doctor will test for these antibodies before and during treatment with Immunogam . your child will be carefully checked by their doctor for signs of hepatitis b virus in haemodialysed patients . vaccination against hepatitis b may result in an immune response that includes trace amounts of measurable hepatitis
immunogam must not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). if you know that you have an iga deficiency , or if you suspect you may have had an allergy reaction to iga containing products . children and adolescents ( aged 18 years and older ) immunogloglobulin can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also include nausea ( arthralgia ), joint pain , low blood pressure and
always use immunogam exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . vaccination against hepatitis b virus : the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). dosage and administration prevention the recommended dose of hepatitis b is 500 micrograms given every 24 hours for 72 days . your doctor will decide how many days you should be vaccinated . hepatitis b in haemodialysed patients : the recommended recommended dose is 500 mbq given every 2 weeks , followed by seroconversion following vaccination activities . immunog
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 1 , 000 ) rare : very rare : may affect up to 1 in 10 , 000 not known very rare cases : these effects may be serious or life - threatening and may lead to undesirable effects . clinical trials have been reported in patients receiving immunog
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2c 8c ). do not freeze . keep the vials in the outer carton in order to protect from light . the product may not be used if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin ( hbv ). - one vial contains 1 mg or 5 mg of human plasma protein , corresponding to a concentration of 96 micrograms / ml . - the other ingredients are polysorbate 80 and water for injections ( see section 2 ). what Immunogam looks like and contents of the pack immunogamer is a solution for injection in a glass vial . the solution is a clear to slightly opalescent , colourless to pale yellow liquid . it is supplied in packs containing 1 or 2 vials . not all
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' ntpf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) and psoriasis in adults , adolescents and children aged 6 years and older . crohn ' s
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to the active substance if you have tuberculosis ( tb ) or another serious infection , e . g . pneumonia , sepsis or heart failure if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : - you have been taking or might take any other medicines . you have recently taken or may take any more remic
always use remicade exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . rheumatoid arthritis the usual starting dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual dose is 5 mg for each kg of weight . your doctor will tell you how many treatments you need . how and when you will be treated the recommended dose is one infusion ( drip ) over 2 hours .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious side effects and may require treatment . tell your doctor or nurse straight away if you notice any of the following side effects during or after your treatment with remicade : signs of an allergic reaction include swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild and disappear within a few days . if you have an allergy reaction , tell
remicade will be stored by the health professionals at the hospital or clinic . the storage details are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if remicade is prepared as a concentrate for solution for infusion , it should be used immediately . however , if not used immediately , in - use storage times and conditions prior to use are the responsibility
what remicade contains - the active substance is infliximab . each vial contains 100 mg of inflixamab . after reconstitution , each ml contains 10 mg ( 10 mg / ml of the solution ). - the other ingredients ( excipients ) are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate , and water for injections ( see section 2 , " important information about some of these ingredients "), and ethanol ( ethanol ( alcohol ) ( please refer to section 4 ), water for injection , and sugar ( non - alcoholic ). what rem
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine that is used by the healthcare professionals at the hospital where you are being treated ) to improve movement control in adults and children of all ages . in people with parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical that is essential for the brain to work properly . movement control is thought to work by helping your body make better use of its own dopamine .
do not take rasagiline mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used in the treatment of depression and parkinson ' s disease . - medicinal or natural products containing st . john ' s wort . - pethidine , a strong pain killer . children and adolescents do not give this medicine to children or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . you can take rasagiline mylan with or without food . try to take your daily dose at about the same time each day . it does not matter whether you take it with food or with alcohol . swallow the tablet whole with a glass of water . do not crush , chew or break the tablet before swallowing . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of the combination of rasagiline mylan and placebo have been reported with frequency not known ( cannot be estimated from the available data ). very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth ,
what rasagiline mylan contains - the active substance is raspiline . each tablet contains a single dose ( 1 milligram ) of raspeline . - the other ingredients are microcrystalline cellulose ( e460 ), tartric acid , maize starch , pregelatinized maize starch ( maize starch ), talc , stearic acid , and water for injections ( see section 2 ). what rasaga mylan looks like and contents of the pack the tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with
do not use hulio : if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection ( tuberculosis ). if symptoms of infections include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . warnings and precautions allergic reaction allergic reactions are symptoms of an infection such as chest tightness , wheezing , dizziness , swelling or a rash . tell your doctor or nurse straight away if you notice any of these reactions . infections you or your child may have an infection
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years of age weighing 10 kg or more the usual starting dose is 30 mg once a day . hulio will be given as 20 mg twice a day ( 1 tablet in the morning and 2 tablets in the evening ). in the case of an emergency , your doctor may instruct you to increase your dose to a maximum of 40 mg once daily . enthesitis in arthritis in infants from 6 to 17 months of age
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections ( see end of section 2 under ' important information about some of the ingredients '). - the solvent is clear to opalescent and colourless to pale yellow and has a rubber stopper . - pack size of 1 , 2 , 1 , 1 sterile injection syringe with 1 sterile needle and 1 sterile vial adapter , 2 alcohol pads , a pre - filled syringe and
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which are used to reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox : if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma , skin allergy or intense inflammation in your nose . warnings and precautions talk to your doctor , pharmacist or nurse before using yellox if you : are using other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used in combination with topical steroids ( cortisone ) which may increase the risk of unwanted side effects . if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in the affected eye ( s ) once a day . if you use more yellox than you should if you accidentally use too many drops , talk to a doctor or go to a hospital straight away . you may need to take the drops for the next day or two after your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 milligrams ( mg ) ( 4 . 0 micrograms ) ( 10 . 1 microgram ) ( 5 . 5 microgram ). - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . it is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo : if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had any condition affecting your breathing ( e . g . asthma , wheezing or shortness of breath ) while you are being treated with this medicine . your doctor may want to monitor your breathing more closely during treatment . you have recently had a head injury or brain tumour . if any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for single use only . do not take more than the recommended dose of this medicine . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed whole with a glass of water . the tablet can be divided into equal doses . the doctor or nurse will show you how to take it with or without food . if you cannot take the tablet with food ,
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems , especially slow and shallow breathing . stop taking dzuveo and see a doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea ( feeling sick ) - vomiting ( being sick ) and feeling hot ( being hot ( feeling hot , feeling dizzy or dizzy ) common side effect ( might affect up to 1 in every 10 people ) - inability or difficulty sleeping - feeling anxious or confused
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . any unused medicine or waste material should be disposed of in accordance with local requirements for medicines . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each single - dose tablet contains 30 mg . - the other ingredients ( excipients ) of the tablet core are : tablet core : mannitol ( e421 ), dicalcium phosphate , hypromellose ( e464 ), croscarmellose sodium ( e468 ), indigo carmine ( e132 ), stearic acid , magnesium stearate . tablet coating : white to off - white , round edges . each carton contains 3 tablets . each pack also contains asingle - dose applicator ( labelled [ sub
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body or cannot be removed by surgical treatments . it also helps to prevent sensitive prostate cancer from returning to the body after surgical treatment . it reduces the levels of testosterone in the blood in men with resistant prostate cancer . erleada also blocks the effects of androgens , which are involved in the growth and spread of the cancer . by blocking the effects , androgens can increase the number of prostate cancer cells .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine may cause seizures . tell your doctor if you take , have recently taken or might take any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ) if you have any heart or blood vessel conditions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg tablet once a day for up to 60 days . your doctor will tell you how many tablets of erleada you need to take . this medicine is for oral use . take the tablet by mouth with food . do not crush , chew or break the tablet . if you take more erleade than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . taking other medicines please tell your doctor , pharmacist or nurse if
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms ( toxic epidermal necrolysis ). other serious side effects tell your doctor or pharmacist if you notice any of these side effects : fits ( seizure ) uncommon ( may
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of appalutamide ( as mesilate ). - the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose ( e460i ) and silica ( e572i ). tablet coating : silica . tablet coat : iron oxide black ( e172 ), iron oxide yellow , macrogol , polyvinyl alcohol , talc , and titanium
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out scan ( a pet scan ) in adult men who have previously had treatment for prostate cancer . it may be used together with other tests to determine prostate specific antigen ( psa ), the type of antigen that is present in the cancer . an axumin pet scan will help your doctor determine whether the cancer has responded to the test . the scan will be done under the supervision of a doctor who is experienced in the use of this type of medicine . your doctor and the nuclear medicine doctor have considered
do not use axumin : if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin . if you have kidney problems . you must follow a low sodium diet . before you are given axumin , you will have a day before the axumin scan ( see section 4 " important information about some of the ingredients of the medicine "). during the scan , you may take your usual medicines for the latest 60 minutes . you may also take one or more of these at the same time
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used in each case . the usual dose is 370 megabecquerel per kilogram of body weight . if you are given more axumin than you should if you have been given too much axumin , tell your nuclear
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were observed : very common ( may affect more than 1 in 100 people ): when using the medicine , side effects associated with axumin may occur in up to 1 out of 100 people : pain , rash , altered taste in the mouth , altered sense of smell . when using this radiopharmaceutical , low amounts of ionising radiation may increase the risk of cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label and carton after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg ( 10 mg / ml ). - the other ingredients ( excipients ) are : powder for concentrate for solution for infusion : pregelatinised solution for injection : one vial of axumin 3200 micrograms contains 3200 mg ( 8 . 5 mg / l ). - solvent for solvent for inhalation : non - reconstituted solution for use in children , adolescents and adults ( 12 years of age and older ) the other ingredient ( s ) are sodium citrate , concentrated
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor , pharmacist or nurse before taking azopt . the same allergy may apply to some people : if you develop too much acidity in your blood ( hyperchloraemic acidosis ) if any of these apply to you , tell your doctor before taking
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the affected eye each day . do not use azopt in both eyes for 1 hour , 2 hours and 3 hours . take the azopt bottle with you . wash your hands after using it . remove the cap . the cap can be removed with a snap collar . hold the bottle tightly with your thumb or finger . tilt your head back . pull down your eyelid with a clean finger until there is a ' pocket
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects on the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects affecting the eye ): sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red , swelling or deposits in eye , glare , burning sensation ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special temperature storage conditions to protect from infections . a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of a suspension . - the other ingredients are : benzalkonium chloride , carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing three
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called medicines taken by mouth to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to treat the following diabetes types : type 1 diabetes : your body does not make enough insulin to control the level of diabetes in your body . your body is not able to use any insulin that your body makes . your doctor may ask you to change your diet , exercise , and how often you exercise . diet and exercise for example , if you
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : if you experience feeling sick or being sick ( stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness ), a sweet smell to your breath , a sweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor or pharmacist immediately if you have one of the above symptoms .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is between 10 mg and 5 mg once a day . if you have a liver problem , your doctor may prescribe a lower dose . your doctor will tell you how many tablets to take and how often to take them . the usual starting dose is one tablet each day . for example , in case of type 1 diabetes , you may take one tablet every day for 5 days . taking this medicine swallow the tablet whole with a glass of water . forx
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice any of the following serious side effects : angioedema ( rare , may affect up to 1 in 10 , 000 people ): if you experience any of these , including swelling of the face , tongue or throat that may cause difficulties swallowing , hives and breathing problems , seek medical advice straight away . diabetic ketoacidosis ( very common ) in patients with type 1 diabetes ( common ), and in patients less than 10 years of age : if you have type 2 diabetes
what forxiga contains - the active substance is dapagliflozin . eachforxiga 5 mg film - coated tablet ( tablet ) contains a single tablet of dpaglifllozin propanediol monohydrate equivalent to 5 mg dopaglifliozin . - the other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 ' for important information about lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , yellow
mifamurtide belongs to a group of medicines called cytokines , which stop the growth of certain bacteria by the immune system . mepact is used to treat adult patients with osteosarcoma ( bone cancer that has spread between 2 and 30 years ) when it cannot be removed by surgery to remove the tumour . it is given in combination with chemotherapy which stops cancer cells from growing and cancer is likely to come back .
do not take mepact if : you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines containing ciclosporin and other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ). you have problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor , pharmacist or nurse before starting treatment : if you have long - lasting
treatment mepact will be given to you by a doctor or a nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose of mypact is 2 mg of mifamurtide every 12 hours . your doctor may increase your dose to 24 mg once a day depending on your mepact treatments and on your chemotherapy schedule . your chemotherapy will be repeated every 36 hours . how to prepare and administer treatment you will always be given a clear and colourless liquid . it is very important that you do
like all medicines , mepact can cause side effects , although not everybody gets them . tell your doctor immediately if you experience chills , fever or fatigue after you have been given mypact . these may be transient . your doctor may give you paracetamol to reduce the risk of fever during treatment . if you have stomach problems ( nausea or vomiting ) or loss of appetite after chemotherapy , contact your doctor or the nearest hospital immediately . continuing fever and chills may occur up to 8 weeks after your last dose of the medicine ( see section " warnings and precautions "). if you are being treated for an infection (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial in outer carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 months . this medicine must not be used if you notice any visible signs of deterioration .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg ( 0 . 07 % w / w ). the other ingredients are 1 - palmitoyl - 2 - ol - sn - glycero - 3 - phosphocholine ( see end of section 2 ) 2 - dileoyl , 2 - nicolyl , 3 - phosphate - l - serine monosodium salt ( see section 2 for further information ). what me
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness associated with rosacea ( redness of the face ) and to reduce the amount of blood that reaches the surface of the skin after a certain period of time , which can be caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of theskin . mirvaso acts by stopping the blood vessels from tightening , thus reducing the excess blood flow and redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 , " contents of the pack and other information "). see section 2 " possible side effects ". warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the medicine should not be injected under the skin . if you take certain medicines used to treat depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso should only be applied to the skin on the face . do not apply this medicine to other parts of your body . if your body surfaces , such as your eyes , mouth , nose or vagina , contact your doctor . if you have the impression that the effect is too strong or too weak , talk to your doctor and pharmacist . how much to use your doctor will tell you exactly how many capsules to use . the recommended dose is one capsule twice a day .
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . stop the treatment immediately and contact your doctor if you have symptoms ( see section 2 " warnings and precautions "). contact allergy : allergic reaction may include rash , rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after first opening , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless dilution has
what mirvaso contains - the active substance is brimonidine . each millilitre of gel contains 3 . 3 mg ( 1 . 5 mg ) of bromonidine tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 under " important information about methylparhydroxy benzoate ") and shellac ( e904 ). - the ingredients in the solvent are ethyl alcohol ( e1203 ),
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body from infection and cancer by blocking the activity of a protein called human vascular endothelial growth factor ( vegf ), which is found in large amounts in the lymph vessels of the body . how mvasi works the vgf protein stimulates blood vessels to expand , thus increasing the amount of oxygen that can be carried around the tumour .
you must not be given this medicine : if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you ( or your child , if they are allergic to other human or chinese hamster ovary ( cho ) cell products ( see section " other medicines and mvasi "). warnings and precautions talk to your doctor or pharmacist before you are given the medicine if : you are pregnant or breast - feeding , think you may be pregnant or are planning to have a baby , ask your doctor for advice before being given mvas
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . the dose may be increased or decreased by your doctor depending on the severity of your condition and the number of infusions you receive . your doctor may increase your dose or decrease your dose depending on how you respond to treatment with this medicine . if you have the impression that the effect of the medicine is too strong or too weak , talk to your doctor or pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special temperature storage conditions . after dilution , chemical and physical in - use stability of infusion solutions has been demonstrated for 24 hours at 2 to 8 oc . from a microbiological point of view , the infusion solutions should be used immediately . in a sterile environment , dilution should be performed under the supervision of a qualified healthcare professional and in accordance with local requirements . if not used immediately , in -
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg / ml ( 1 . 4 mg / 16 . 5 mg ) solution for injection . each 4 ml vial contains 100 mg ( 2 . 0 mg / 25 ml ). - each 400 mg vial delivers 400 mg ( 4 . 0mg / 100 ml ) solution . - the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasoi looks like and contents of the pack mvasis is a concentrate for solution for infusion .
tecartus is a gene therapy medicine used to treat mantle cell lymphoma ( mcl ) in adults . it is used in combination with other medicines to treat adults . tecartus works by reducing the number of your own white blood cells ( called autologous anti - cd19 - transduced cd3 + cells ) in your body at a rapid rate . mcl is a cancer that affects the immune system ( the body ' s natural defences ). b - lymphocytes are a type of cell that are involved in the growth and spread of the cancer . they are found in large amounts in lymph tissue such as the
do not use tecartus : if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : you have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ) you have or have had problems with a number of these types of white cells ( autologous use ). your doctor may do tests ( checks ) to check your lungs , heart , kidney
tecartus contains your own white blood cells . your cells will be collected and given to you via a catheter placed in your vein ( a procedure call leukapheresis ). the number of these cells is very small . how tecartus is given you will be given a single infusion of your white blood cell into your blood . the first dose of your blood is given into a vein over a period of 3 to 6 hours . if you have any further questions on the use of this product , please ask your doctor , pharmacist or nurse . how long the treatment will last your doctor will decide how long you will
like all medicines , this medicine can cause side effects , although not everybody gets them . if any of your side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or nurse . you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 ml . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - cd19 car t cells in approximately 68 ml ( corresponding to 2 x 106 anti ) cells . - the other ingredients are sodium chloride and human albumin ( see section 2 for further information about some of the ingredients ). - the concentrate for solution for infusion is reconstituted in an infusion bag ( a metal cassette ) and diluted in a sterile water for injections . once a patient has been prepared , asingle infusion bag
januvia contains the active substance sitagliptin which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which help to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar ( glucose ) in the following situations : - if you are already taking one or more of the following medicines , your doctor may prescribe this medicine alone to lower blood sugar : -
do not take januvia : if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had blistering of the skin ( bullous pemphigoid ) or if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before taking this medicine . your doctor may want to monitor you more closely . you have a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg once daily depending on how you respond to this medicine . your doctor will tell you how many tablets of this medicine to take . this medicine may be taken with certain other medicines that lower blood sugar . it is important that you continue to follow the advice about diet and exercise given to you by your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ): rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg of sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , and sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what j
xultophy helps to control blood glucose in patients with type 2 diabetes mellitus . diabetes is when your body does not produce enough insulin to control the level of blood sugar . your doctor has prescribed insulin degludec ( a long - acting basal insulin ) to help control your blood sugar levels . liraglutide ( a type of glp - 1 ) is a substitute for insulin during meals . xultophy can be used alone or with oral medicines . when you are taking diet and exercise alone if you are unable to take oral medicines , such as metformin , pioglitazone or sulf
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor will tell you how long you should continue to take your sulfonyllurea dose . it is important that you continue to follow the advice about diet and exercise given to you by your doctor , pharmacist or nurse . your blood sugar levels should be checked regularly before and during treatment with x
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . do not take more than one tablet in the morning , with breakfast , with dinner . if you have been blind or have poor eyesight , your doctor may need to adjust your dose to maintain your blood sugar level . your doctor will tell you how many tablets of xultophy to take and how long you should continue to take them . the usual starting dose is 41 mg twice a day ( 1 tablet of insulin deglud
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common : may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). if you are not sure about any of these , talk to your doctor or pharmacist before taking xultophy . warnings and precautions : check with your doctor , pharmacist or nurse if you have ever had low blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening : store in a refrigerator ( 2 8 ). do not freeze . store in the original package in order to protect from light . after opening : chemical and physical in - use stability has been demonstrated for 8 hours at room temperature ( up to 8 ). from a microbiological point of view , the product should be used immediately . however , if not used immediately , storage times and conditions
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec 3 . 6 mg / ml ( corresponding to a concentration of 300 units / ml ). - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xulinophy contains sodium "). what xultphil looks like and contents of the pack xultophical is a clear , colourless solution . it is supplied in a
giotrif is a medicine that contains the active substance afatinib . it blocks the activity of two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ] ( erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working properly and stops them from multiplying and growing . this will slow down the rate at which these proteins die and may help to stop cancer cells from growing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non - small cell lung cancer ). g
do not take giotrif : if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you suffer from lung inflammation ( interstitial lung disease ) or liver problems . your doctor may need to perform some liver tests before and during treatment with this medicine . if you know that you have a severe liver disease . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how many tablets of this medicine to take . if you take more giotrif than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . if possible , take the tablet pack with you so that you can easily describe what you have taken . you may find it easier to remember to take your tablets at the same time each day . it is important that you
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea ( very common , may affect more than 1 in 10 people ). if you experience diarrhoehoea , contact your doctor straightaway ( see section 2 " warnings and precautions "). if you have severe diarrhoee ( with or without fluid loss ). common ( may affect up to 1in 10 people ): low blood potassium . worsening kidney function . if you are concerned that you may be at increased risk of having a rash , talk to your doctor immediately . your doctor
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections ( see section 2 ), talc , and sunset yellow fcf ( e110 ) in the tablet core and in the film - coating . what
the active substance in orkambi is lumacaftor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older . it works by blocking a protein called f508del mutation ( cftr ) in the gene responsible for the protein . this protein is a cyst fibrosis transmembrane conductance regulator ( ttr ), a protein that transports radioactivity from the lungs to the cells in the body . if the mutation in the ttr gene results in a reduced ability of the body to transport radioactivity , it causes an abnormal c
do not take orkambi : - if you are allergic to lumacaftor , ivaceaftor or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given , or during your treatment , if any of these apply to you . children and adolescents do not give this medicine to children or adolescents under the age of 6 years because the dose has not been studied in this age group . if you have been told by your doctor that the f508del mutation is present in your child , you should not be given ork
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is one 6 mg tablet once a day for the first 12 weeks . your doctor will tell you how many tablets to take . the recommended orkambi tablet is 6 to 11 mg twice a day . depending on how you respond to the medicine , your doctor may increase or decrease your dose to one or two tablets a day ( for example , one tablet in the morning and two tablets in the evening ). if you have moderate or severe problems with liver function ,
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious and need immediate medical attention . stop taking orkambi and ivacaftor and see a doctor straight away if you notice any of the following serious side effects while you are being treated with this medicine : - raised levels of liver enzymes in the blood - liver injury in patients with pre - existing severe liver disease - the worsening of liver function uncommon side effects ( may affect up to 1 in 100 people ): - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin
what orkambi contains the active substance is lumacaftor . each tablet contains two different strengths ( called " lumaconaftor " and " ivacaftore "). one tablet contains either 100 micrograms ( 3 . 5 mg ) or 125 microgramms ( 4 . 0 mg ) of lumiacaftor ( corresponding to a concentration of 125 microlitres ) or one tablet containing 125 microgа ( 3. 5 mg ). one tablet contain either 200 micrograms ( 5 . 7 mg ) and 200 microgramm ( 6 . 9 mg ) lumacftor ( equivalent to a
the active substance of lynparza is olaparib , a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors cause death of cancer cells by stopping the activity of an enzyme needed to repair dna . the active substance in this medicine is called parp , which is involved in the normal repair of dna in women . what is Lynparza used for ? the treatment of ovarian cancer
you must not be given lynparza : - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children less than 6 years of age . the use in children under 2 years is not recommended . if you have any further questions on the use of this product , ask your doctor or pharmacist . if any of these apply to you ( or you are not sure ), ask your child ' s doctor or nurse . warnings
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose for adults is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg once a day depending on how you respond to the daily dose . the doctor will tell you how many tablets you need to take . if you take more than one tablet a day , take it as soon as you remember and then take your next dose at its regular time . do not take a double dose to make up for a forgotten dose . how to
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ), which may affect up to 1 in 100 people . allergic reactions such as hives , difficulty breathing or swallowing and dizziness may be signs and symptoms of hypersensitivity reactions . other side effects tell your doctor or pharmacist if you notice any of the following : very common side effects these may affect you more than once
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . any lynparza capsules should be disposed of in accordance with local requirements . store in the original package in order to protect from moisture . after first opening of the bottle , store in a refrigerator ( 2 - 8 ). do not freeze . if you are not sure what to do , ask your pharmacist how to dispose of the capsules you no longer use . these measures will help protect the environment
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what the hard capsule looks like and contents of the pack white to off - white opaque , hard capsule imprinted with the company logo on one side and the number " 50 " on the other side . the capsule is embossed with an astrazeneca logo on
this medicine contains the active substance naloxone which is used to reduce the effects of opioids ( such as heroin , methadone , fentanyl , oxycodone , buprenorphine , morphine ). nyxoid is used as a nasal spray during the emergency treatment of opioid overdose in adults , adolescents and children of 14 years of age and older . overdose may cause breathing problems and severe sleepiness . if you experience an opioid overdose , stop taking opioids and seek emergency medical care immediately .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you think you may have an opioid overdose . it is important that you immediately contact your doctor if you have any questions about the signs and symptoms of an overdose . if you forget to use this nasal spray if you miss a dose , take it as soon as you remember and then go back to your regular schedule . however , if it
always use nyxoid nasal spray exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . do not use more than the recommended dose . 1 . seek medical attention immediately if you have symptoms such as : shoulders , ears , breastbone , sternum or inside the ear . fingernail . 2 . clear the mouth and nose of any blockages . breathe in through the mouth or nose . 3 . if breathing is the chest moving through the chest , hear breathing sounds and breath on the cheek . overdose may be life - threatening . response to touch or
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and tell your doctor straight away : acute withdrawal symptoms have been reported in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . this is uncommon ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . one dose of each nasal spray contains 1 . 8 mg ( 10 mg / ml ). - the other ingredients ( excipients ) are hydrochloride dihydrate , trisodium citrate diydrate , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . - the total amount ( mg ) ( 0 . 1 ml ) in a pre - filled nasal spray can be divided into equal doses . a single dose container is sufficient to deliver the full dose . what nixoid looks like and contents of the pack n
this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries , and in the production of sperm . ovaleap is used to produce a viable egg cell after treatment with a medicine called " clomifene citrate ". it is used in adult women undergoing assisted reproductive technology procedures ( procedures to help get pregnant ) and in children and adolescents who are not able to take a medicine known as " lutropin
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone ( fsh ), or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the part of the brain that produces hormones ), large ovaries ( sacs of fluids ) or ovaries that contain ovarian cysts ( unexplained vaginal bleeding ), cancer in your ovaries , womb or breasts , any condition that makes normal pregnancy impossible , ovarian failure ( early menopause ), fibroid tumours of the womb , malformed reproductive
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how long you should continue to use the medicine . the recommended dose is one vial of this medicine containing 75 mg or 150 mg hcg . you will be given this medicine every 7 to 14 days at a dose of 37 .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ). if you experience this type of reaction , your doctor may reduce the dose of your ovaleop injection and tell you to stop using it . tell your doctor or nurse immediately if you notice any of the following . serious side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . after first opening of the vial , this medicine may be stored for a maximum of 3 days below 25 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days at 2 8 , unless the cartridge has been stored
what ovaleap contains - the active substance is follitropin alfa . one ml of solution for injection ( injection ) will be given to you by your doctor , nurse or pharmacist . each cartridge contains 300 micrograms of solution ( equivalent to 22 microlitres of follnitropin alpha in 0 . 5 ml ). each cartridge also contains 450 microgram s of solution when given as a single dose . one dose ( 0 . 75 ml ) is sufficient to give you the desired response . each dose ( 1 . 5ml ) contains the desired effect . - the other ingredients are sodium dihydrogen phosphate
voriconazole accord is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults , adolescents and children from 2 years of age to treat invasive aspergillosis ( a type of fungal infection caused by the Aspergillus sp .) and candidaemia ( an advanced stage of a serious , but potentially life - threatening type of serious , infection of candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count ) to reduce the risk of getting candida Sp . infections when the fungus is
do not take voriconazole accord : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any other medicines . this includes herbal medicines and medicines obtained without a prescription . in particular , tell your doctor or pharmacist if you have any questions about the medicines you are taking , or if any of these apply to you . do not take any more of the medicines mentioned in section 4 of this leaflet . you should inform your doctor if you : 46 are taking terfenadine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be given as 40 mg twice a day for 24 hours . the dose will then be increased to 400 mg two times a day ( for 12 hours ) and then to 200 mg one time a day during 12 hours or 24 hours of 24 hours ( for 100 hours ) at the end of treatment . the recommended dose is 300 mg once daily .
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual
what voriconazole accord contains - the active substance is vorinazole . each film - coated tablet contains 50 mg of voronazole ( as perforated tablet ). - the other ingredients ( excipients ) are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactosemonohydrate and triacetin . the film - coating contains sunset yellow fcf ( e110 ) colour ( e133 ). what v
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older who are at high risk of getting ebola , as part of a 2 - dose course of vaccinations . the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine does not contain any of the other ingredients in the vaccine ( listed in section 6 ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given this vaccine . if you have not been vaccinated against filov
follow carefully all instructions given to you by your doctor , pharmacist or nurse . you should not receive the vaccine : if you have ever had a severe allergic reaction to any ingredient contained in the vaccine ( listed in section 6 . if you think you may have a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine should not be given . warnings and precautions talk to your doctor or nurse before you are given mvabea if any of the following apply to you ( or you are not sure ), or if you are in any doubt at all , consult your doctor before receiving any other vaccine injection : - if
your doctor , nurse or pharmacist will give you the vaccine by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the first dose of vaccination will be given with zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should if you think you may have been given too much , tell your doctor or nurse straight away . the second vaccine should be given at the same time as the first . children and adolescents the recommended dose of vaccine is the same as for adults . primary vaccination first vaccination ( with or without zab
like all medicines , this vaccine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain this is common in children and adolescents ( aged 1 to 10 years ): feeling sick ( vomiting ) itching at the site of the injection this is uncommon in adults ( age 1 to 17 years ). uncommon in children aged less than 1 year : redness , skin hardness at the place the injection was given generalised
what mvabea contains the active substance is zaire ebolavirus 29 produced by recombinant dna technology in tai forest ebolavirus nucleoprotein marburg at a concentration of 0 . 7 to 108 μg / ml . the other ingredients are : chicken embryo embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what movabea looks like and contents of the pack the vaccine is a suspension for injection in a single - dose glass vial with a
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat can also be used if you have a raised calcium level in your blood due to a tumour . it reduces the amount of calcium that is lost from your bones . this helps to stop the bones from getting weaker .
do not take bondronat : if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in cancer - related conditions . if you get onj , stopping treatment may increase your risk of developing onj . onj is a painful condition that can be difficult to treat . therefore , you should be carefully checked by your doctor for any signs of developing osteone
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . patients with cancer the recommended dose is one infusion into your vein once a week . your doctor will carry out regular blood tests while you are being treated with bondronat . the dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 to 3 - 4 weeks for an infusion in your vein . this usually takes about 15 minutes . in case of a raised calcium level in your blood , your doctor may reduce your dose by 1 to 2
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect less than 1 in 10 , 000 persons ): pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . your healthcare professional will ensure that this medicine is used correctly and
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion ( equivalent to 2 mg ibondronic acid ). - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water and water for injections . what bondsronat looks like and contents of the pack 1 vial with a bromobutyl rubber stopper .
what zeposia is and what it is used for it is a medicine that is used to treat adults with relapsing remitting multiple sclerosis ( rrms ), a type of active disease that affects the nerves of the brain and spinal cord . symptoms may include numbness , difficulty in walking , and problems with vision and balance . relapses remitting ms is a disease in which the immune system ( the body ' s defences ) attacks on the nerve cells responsible for transmitting nerve signals , causing them to lose their ability to move and communicate with each other . people with rrrh may have symptoms such as numbness
do not take zeposia : if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severely weakened immune system ( e . g . a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmia ) your heart is not working properly after treatment you have or have had severe infection such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need based on your heart rate . you will be given a ' treatment initiation pack ' for the first 4 days of treatment . the recommended starting dose is 4 capsules of 0 . 23 mg ozanimod per day . this will be gradually increased to 1 capsule in the morning and 4 capsules in the evening . depending on how you respond to treatment , your doctor may increase your daily dose to a maximum of 3 capsules of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( increase in blood pressure ). uncommon : may affect up to 1 in 100 people : allergic reaction . the signs may include a rash . other possible side effects are listed below . very common : side effects may include : common : may effect up to1 in every 10 people : infections of the nose or nostrils , nasal cavity , mouth , throat ( pharyn
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any damage or signs of tampering to the pack , tell your pharmacist .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg of zanimod ( as hydrochloride ). - the other ingredients are : - capsule contents : 0 . 43 mg / 0 . 46 ml ozanimog ( as oxychloride ) - capsule shell : 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 20 , 28 , 30 , 31 , 32 , 33 , 35 , 40 , 56 , 50 , 51 , 60 , 84 , 90 , 98 , 100 , 100 or 200 mg of ozanim
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide , and vilanterol . fluticastonefuroate belongs to a group of medicines called corticosteroids . steroids are substances produced by the body that act in opposite ways to the body ' s own immune system , such as by interfering with the production of hormones ( e . g ., cortisol ) and so reducing the amount of ega that the body can produce . this medicine is used to treat chronic obstructive pulmonary disease ( copd ). copd is a
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . if any of these apply to you , tell your doctor straight away . if you have asthma , your doctor may need to lower your dose of temybi ellipta . your doctor should check you regularly for asthma , heart problems , high blood pressure , liver problems , tuberculosis (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used within 24 hours after your last dose of temybric ellipta . try to use it at the same time each day . do not take more than your doctor tells you to . if you do not feel better after 24 hours , talk to a doctor or go to the nearest hospital straight away . take the pack with you and this leaflet with you so that you can easily describe what you have been taking . if
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) ( copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection ( candidiasis )
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose provides a delivered dose ( the dose leaving the mouthpiece ) equivalent to 92 micrograms of the two active substances . the delivered dose is : one inhalation ( dose leaving your mouthpiece ), two inhalations ( dose adjusting ) and one dose ( dose adjustment ). the other ingredient is trifenatate . the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 under ' important information about lact
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used in adults to treat an infection of the lungs called ' pneumonia '. your doctor will tell you how long you should continue to take it . your doctor may tell you to stop taking it if you do not feel better or if you feel worse after a short time . how zrinforo works your body is able to kill certain bacteria that cause
do not take zinforo : if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( e . g . penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . if any of these apply to you ( or you are not sure ), tell your doctor straight away . you may need to be treated with other antibiotics such as pen
always use zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults the recommended dose is 600 mg once a day for 12 weeks . your doctor may increase your dose to 600 mg every 8 weeks if you get some infections . it may be up to 8 to 12 weeks depending on how you respond to treatment . it is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . if you weigh 120 kg or more , you may receive an increased dose . the duration of treatment is 5 to 14
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zinforo and see a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus may be present . your doctor may decide to change the dose of treatment you are taking , or temporarily stop you taking the medicine , or stop treatment with zin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is ceftaroline fosamil . - the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zincforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain ( pld ) is a severe , long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neurological pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles , and may also be life - threatening . in some patients the severity of peripheral and
do not take pregabalin pfizer : - if you are allergic to pregaabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . some patients who have recently taken pregagabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . the severity of these reactions may vary from patient to patient , but are generally mild to moderate . during post - marketing use , some patients taking pre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder the usual dose is one 150 mg capsule twice a day . your doctor may increase your dose to 600 mg once a day depending on how you respond to the medicine . you should swallow the capsule whole with a glass of water . do not crush , chew or break the capsule . you may take the capsule with or without food . you can take the capsules at any time of the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance , fall . dry mouth , const
what pregabalin pfizer contains - the active substance is preginabalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of preginibalin . - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica ( e551 ). - the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical that is involved in movement and is important for the brain to function normally . in parkinson ' s disease , changes in the amount of dopamine produced occur in the body . these changes can lead to sudden swings in the ability to move and difficulties moving . xadago can be used alone or in combination with the medicine levodopa , or other medicines used to treat the condition .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine ( for treatment of parkinson ' s disease or depression ). pethidine ( a strong pain killer ) ( see section 7 " warnings and precautions "). if any of these apply to you ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . xadago is available in two strengths : 50 mg and 100 mg . the recommended dose is one tablet taken by mouth once a day . your doctor will prescribe the strength that is right for you . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take your tablet at about the same time each day . you should swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . if necessary , you can take xad
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis : very high blood pressure may lead to collapse ( neuroleptic malignant syndrome ). signs may include confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness and hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa and other medicines used to treat the condition : common ( may affect up to 1 in 10 people ): insomnia
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet is made up of the following ingredients : - the other ingredients are aspartame , methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol ( 6000 ), titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadadago looks like and contents of the pack yadago 50 mg are white to off - white
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga lowers testosterone ( androgen deprivation therapy ) in men when they are treated with another medicine to treat the same disease , called hormone therapy . this is a treatment that lowers testosterone (' androgen depletion therapy ') in men . your doctor may prescribe another medicine , prednisone . prednisolone is used in adults to treat high blood pressure in the body because it reduces the amount of fluid retention in your blood .
do not take zytiga : if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before you are given ztiga . if you have severe liver damage or prostate cancer . this medicine should not be given to children under the age of 18 years . if any of these apply to you , do not take this medicine and tell your doctor before taking this medicine . if your doctor has told you that you have liver problems such as high blood pressure or heart failure
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . your doctor will tell you how many tablets of this medicine to take and how long you should continue to take it . this medicine is for oral use . swallow the tablets whole with a glass of water . you can take the tablets with or without food . do not chew , crush or split the tablets . it is important that you take zytiga every day until your doctor tells you otherwise . if you have the impression that the effect of z
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor will check your potassium regularly . other possible side effects may include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet . low blood potassium ( seen in liver function test ). high blood pressure . urinary tract infection . diarrhoea . common : may affect up to 1 in every 10 people :
what zytiga contains - the active substance is abiraterone acetate . each tablet contains nominally 250 mg abirate acetate - the other ingredients are : - tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " important information about some of the ingredients in this medicine " for further information on the contents of this medicine . what ztiga looks like and contents of the pack - zyt
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . the active ingredient in hefiya , addalimumab , is a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). monoconlonal antibodies are proteins that recognise and attach to specific targets in body cells . the target of adal
do not take hefiya - if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if you have a severe infection , such as tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . warnings and precautions your child may have moderate or severe heart failure or have a serious heart condition . allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheezing , dizziness , swelling or rash .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor will tell you how many tablets to take . the dose may later be increased to 20 mg , 40 mg , 20 mg or 40 mg . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults and children from 2 years of age weighing 30 kg or more 40 mg every other week starting from 2 to 10 kg and increasing to 30 mg or 20 mg every week . enthesitis - related arthritis
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months after the last hefiya injection . signs of allergic reaction may include heart failure , severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . signs and symptoms of infection may include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired or coughing . symptoms of nerve problems may include ting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . from a microbiological point of view , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adlimumab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol ( e421 ), polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections ( see section 2 " important information about some of the ingredients of this medicine "). what hefaya looks like and contents of the pack hafiya 20 mg solution for injection ( injection ) is a clear to slightly
the active substance in ritemvia is called rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the target protein it allows the cell to grow and divide . by sticking firmly to a target protein called " cd20 " it helps your immune system ( the body ' s natural defences ) to increase the number of red and a - lymphocytes ( these are the cells that help your body fight off the hodgkin ' s lymphoma
do not take ritemvia : - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees ( needles ) or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection with a weak immune system if you suffer from severe heart failure or severe uncontrolled heart disease if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children or adolescents under 6 years of age because it has not been studied in
you will be given ritemvia under the supervision of a doctor experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this will help you to get the best results and reduce any side effects . your doctor will decide how many treatments you need and will tell you how often you need to use it . the recommended dose is one tablet once a day . it is given as a drip ( intravenous infusion ). your doctor may change the number of medicines you take at each ritemvia administration . you may also be
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what ritemvia contains - the active substance is called rituximab . each ml of concentrate contains 100 mg ( 10 mg / ml ) of ritukimab ( as besilate ). - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 , water for injections and solvent for solvent for injections . what it looks like and contents of the pack this medicine is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva is a type of medicine known as a cytokostatic medicine . it is an active anti - cancer medicine that works by blocking the action of a substance called epidermal growth factor receptor ( egfr ), which is present in large amounts on the surface of colon , rectal , gastric , or breast cancers . in these tumours , the removal of the tumour by surgery is usually required . in this case it is used alone or in combination with other
do not take capecitabine teva - if you are allergic to cape citabine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : - have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines called fluorouracil ) - are pregnant - have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe you a dose and treatment regimen that is right for you . the recommended dose of cape citabine teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once a day . for children and adolescents ( 6 years of age and above ), the usual starting dose is one tablet once a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you experience any of these symptoms : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movements . if you get any diarrhea at night ( vomiting , vomit , nausea ) or if you lose your appetite ( stomatitis ) pain , redness , swelling or sores in your mouth and / or throat ( hand or foot ) skin - reaction : pain , swelling and redness or tingling of hands and /
what capecitabine teva contains - the active substance is capecabine . each film - coated tablet contains 150 milligrams ( mg ) capecitabeq . each tablet contains 500 milligram ( mg ). - the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , talc . tablet coating : hypromellaose , titanium dioxide ( e171 ), yellow iron oxide ( e172 ) and red iron oxide [ e172 ] ( see section 2 ). what
silodosin recordati is a medicine that belongs to a group of medicines called alpha1a - adrenoreceptor blockers . it works by blocking the activity of these receptors in the prostate , bladder and urethra . this helps to maintain smooth muscle in these tissues . it also reduces your symptoms . your doctor will tell you how long you should continue to take this medicine and will explain to you why this medicine has been prescribed for you . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not use silodosin recordati : - if you are allergic to siliodosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . during eye surgery , cloudiness of the lens may occur . during cataract surgery , the eye will be examined 26 carefully . your doctor will tell you if you need to be treated again . if you think any of these apply to you , tell your doctor or pharmacist as soon as possible . you may need to have a surgery while you are being
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is 8 mg once a day . patients with kidney problems if you have moderate kidney problems , your doctor may prescribe a lower dose . your doctor will prescribe the dose that is right for you . swallow the capsule whole with a glass of water . do not chew , crush or split the capsule . you can take the capsule with or without food . it is best to take it at the same time each day . if you take more sil
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect of silodosin recordati is dizziness . if you experience dizziness and / or occasionally fainting , you may feel weak or dizzy . if the symptoms of dizziness are severe , you should contact your doctor as soon as possible ( see also under " warnings and precautions " and " other possible side effects "). if you have complications from a cataract surgery (
what silodosin recordati contains - the active substance is silodusin . each capsule contains 8 mg of siliodosin . - the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : shellac ( e904 ), silodosein ( e464 ), aluminium ( e553b ), iron oxide ( e172 ) ( see end of section 2 ), calcium ( e468 ) ( e470b ) and magnesium ( e524b ). printing ink : shellack (
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow . this results in an increase in your blood pressure , which can be harmful to your everyday life . kinzealmono blocks this effect . this means that both of the ingredients in this medicine work together so that the blood vessels relax , and yourblood pressure is lowered . your doctor has prescribed kinzaloono for the treatment of essential hypertension ( high blood pressure ) in adults . ' essential ' means that the high
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not take this medicine and talk to your doctor , pharmacist or nurse before taking it . if you ( or your child ) are more than 3 months pregnant , think you may be pregnant , or are planning to have a baby . ( see section " pregnancy and breast - feeding "). if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets can be taken with or without food . if you take more kinzalmono than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . your doctor will tell you how many tablets to take . if possible , take the tablets with a glass of water . do not crush or chew the tablets . if necessary , your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . other side effects of kinzalmono common side effects (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . keep your medicine bottle tightly closed in order to protect from moisture . remove your kinzalmono tablet from the blister only directly prior to intake .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate in the tablet core and in the film - coating ( see end of this section for important information about some of the ingredients ). what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round tablets , embossed with " gsi " on one side and
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). the active substance is lonoctocog alfa . afstylfa is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor iii is involved in blood clotting and is necessary for blood to clot . patients with an increased tendency to bleed have been shown to have been more likely to have had factor iii deficiency in the past . however , in patients of all ages , including those from a certain age
do not use afstyla : - if you have ever had an allergic reaction to human proteins . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - are allergic to hamster proteins 46 - are breast - feeding . you should not breast - feed while you are being treated . if you are not sure if any of the above applies to you , ask your doctor or pharmacist for advice before you receive this medicine . check with your doctor and pharmacist if you think any of these apply to you . do not stop your treatment unless your doctor tells you to .
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one vial of afstyla per day . dose and duration of treatment depending on the severity of your disease the site and location of the bleeding your clinical condition will be decided by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used immediately after preparation . in case of aseptic conditions , the solution should be mixed with other medicines
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure and dizziness ( anaphylaxis ). bleeding has been reported in patients treated with factor viii medicines ( inhibitor antibodies ) ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) - if you have received previous treatment with factor iii ( more than 150 days of treatment ), the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2 - 8 unless dilution has taken place
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg / ml ) solution for injection . after reconstitution , one ml of solution contains 100 iu loroctocag alfa ( 99 . 9 %) solution for injections the solution is supplied in a vial containing 200 iu / ml ( 100 micrograms ) solution prior to administration and after administration . the recommended dose is : one vial of solution for infusion contains 200 microlitres ( 100 million iu ) solution per vial . after administration and
what praxbind is and what it is used for the active substance in this medicine , idarucizumab , is a recombal agent . it dissociates from dabigatran ( pradaxa ), which is a blood thinner medicine used to prevent blood clot formation . what you have been given by your doctor , pharmacist or nurse is given to you by a doctor or nurse . they have given you this medicine so that you are able to rapidly trap dabrigatran . what are the benefits of having Praxbind ? if you are given too much of one of the active substances in this
do not use praxbind : if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 . if you have a genetic disease called hereditary fructose intolerance ( hfi ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . serious adverse reactions have been reported with patients taking this medicine in combination with dabigatran . other medicines may increase the risk of blood clots ( see section " other medicines and the use of dabigATran "). your doctor may want to monitor you more closely as it reduces the chances of blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg film - coated tablet of 2 . 5 mg dabigatran per day to be taken orally with or without food . you will be given this medicine once a day for 5 days . this medicine is given into a vein ( intravenously ) by your doctor . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . your treatment will be overseen by a doctor who is experienced in the treatment of blood clot formation .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ) and polysorbate 20 ( e433 ). - the solvent for injections is water for injections ( see section 2 " important information about some of the ingredients of Praxbind "). what it looks like and contents of the pack the concentrate for solution for injection is clear to slightly opalescent and colourless to slightly yellow solution . it is supplied in a clear glass vial with a butyl rubber stopper and an
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . - in children and adolescents ( 3 years of age and older ) - in adult patients who have not previously been treated with radiotherapy ( concomitant phase of treatment ) or monotherapy phase oftreatment ( see section 3 for further information ). - in patients with malignant glioma , such as gliOBlastoma multipurpose or anapl
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ), your white blood cell count and platelet count may decrease . these blood cells help you in fighting infection and are important for proper blood clotting . your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before you start or during treatment . your doctor may adjust your dose if you experience nausea or vomiting . patients with newly - diagnosed glioblastoma multiforme treatment will be divided into two phases :
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache . temomedac treatment may cause a reduction in certain kinds of blood cells . this may result in increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be life - threatening
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . after first opening , the capsules should be used within 30 days . if you notice any change in the appearance of the capsules , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains ∑ the active substance is temozolomide . ∑ each capsule ( desiccant ) releases 5 mg ( 10 micrograms ) per kilogram of body weight , each time the dose is increased to a maximum of 20 mg ( 20 milligrams ) per day , depending on the dose you need to take to keep up with your daily dose on the daily basis on the day of the week on which the dose increases to a minimum of 100 mg ( 100 milligram ) once a day on the morning of the day on a day off on the days on which temoz
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis will only help you to obtain a hard erect penis if you have agreed with your partner that it would be appropriate for you to engage in sexual activity with a man who could provide the necessary sexual activity for a man to have a hard erection . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors , which work by reducing the activity of the blood vessels in your penis . this will help your
do not take cialis if : you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) you are taking any form of organic nitrate or nitric oxide donors ( e . g . amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines : if you have been taking nitrate for a long time you have serious heart disease you recently had a heart attack within the last 90 days you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual starting dose is between 5 mg and 2 . 5 mg per day . your doctor will tell you how many tablets to take . do not take more tablets than your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions including rashes ( frequency not known ) and chest pain have been reported in patients taking nitrates . the frequency is not known ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . stop taking cialis and get an erection straight away ( see section 4 " warnings and precautions "). contact your doctor immediately if you experience sudden loss of vision . this is not of the frequency listed above . other side effects very common ( may
what cialis contains - the active substance is tadalafil . each 2 . 5 mg film - coated tablet contains a tablet that contains a desiccant called lisinopril . - the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : cellulose ( e460i ) and hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your body . the insulin that your body makes does not work as well as it should . your doctor will tell you how many treatments you need and how long you should continue to follow the advice about diet and exercise that your doctor has given you . you should check with your doctor if you are not sure . it is important that you continue to
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . this could lead to diabetic ketoacidosis . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you have liver problems . you have moderate liver 28 disease . see section 2 . do not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . try to take your daily dose at about the same time each day . this will help you remember to take it . however , if it is almost time for your next dose , skip the dose you missed and go back to your regular schedule . do not take a double dose to make up for a forgotten dose . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia ( the most common side effect of enyglid ) is very rare ( may affect up to 1 in 10 , 000 people ) but is extremely serious and needs immediate medical attention . if this happens to you , contact your doctor or the nearest hospital straightaway ( see also section 2 ). signs and symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( signs of anaphylactic reaction ). other side effects include : very common ( affects more than 1 user in 10 ): stomach pain diarr
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet only in 2 mg tablet . tablet coating : red ironoxide ( e 172 ) only for 2 mg tablets only in 0 .
azacitidine mylan is an anti - cancer agent . your doctor or nurse will tell you how to use it . it is very important that you do not try to kill yourself . do not shake vigorously as this may affect your ability to do so . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
you must not be given azacitidine mylan - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you have advanced liver cancer . your doctor may want to monitor you more closely . you should tell your doctor if you : have decreased counts of platelets , red or white blood cells , kidney disease or liver disease have a heart condition ( such as heart attack or lung disease ) your doctor will ask you to have blood test periodically during treatment with azac
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet of this medicine per day . your doctor will work out your dose based on your height and weight . you will usually receive one tablet once a day . if you miss a dose , take it as soon as you remember and then take your next dose at its regular time . do not take a double dose to make up for a forgotten dose . how much to take the usual starting dose is two tablets twice a day ( one tablet in the morning and one in the evening ). your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these could be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these may be symptoms or signs of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . after reconstitution , the medicine must be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 1 hour at 2 8 . if you are not able to use the az
what azacitidine mylan contains powder : one vial contains 100 milligrams ( mg ) of azacituidine . after reconstitution , 4 ml of water for injections should be used immediately . the reconstituted suspension contains 25 mg / ml ( 0 . 5 %) azaccitidine . the other ingredients are mannitol ( e421 ) ( see section 2 ). what azacité mylan looks like and contents of the pack aciaitidine milan is a white powder for suspension for injection in a glass vial . each pack contains one single - use vial containing 100
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol , in one single drop . both of these active substances work together to reduce the amount of fluid within the eye , which is increased by the absorption of light from the eye into the eye by the eye ( glaucoma ).
do not take duotrav : if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat ), heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if your eye becomes cloudy . warnings and precautions talk to your doctor or pharmacist before taking duotra : in the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes once a day . do not use duotrav in your eyes unless your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how to use your eyes your doctor will tell you how many drops to use and how often to use them . the recommended starting dose is two drops ( 1 , 2 , 3 , 4 drops ) per day .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the effects above , stop using duotrav and talk to your doctor immediately . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness ( frequency cannot be estimated from the available data ) ( commonside effects may affect up to 1 in10 people ) problems of theeye eye surface inflammation or surface damage including eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . after first opening , use within 4 weeks to prevent infections .
what duotrav contains - the active substance is travoprost ( as timolol ). each vial contains 40 micrograms ( 10 microlitres ). - the other ingredients ( excipients ) are propylene glycol , polyoxyethylene hydrogenated castor oil 40 %, boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodiumhydroxide ( to reduce acidity levels and ph levels ) and water for injections ( for example , in a glass vial ) and in a clear , colourless solution in a 2 . 5 ml plastic bottle
nplate ' s active ingredient is romiplostim . it is a protein that is used to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in protecting your blood from blood clots and so can help prevent blood from getting in and out of the stools . very lowplatelet counts can lead to bruising and serious bleeding ( see section 1 ) if you have had your spleen removed ( chronic itp
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking nplate : if you have a low blood platelet count ( thrombocytopenia ). if this applies to you , your doctor may reduce your dose of nplate , temporarily or permanently , or permanently . your doctor will also monitor your platelet counts to check for blood clots . if you suffer from blood clotting ,
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( from 1 to 17 years of age ) the recommended dose of nplate is one tablet once a day . your doctor will decide how much nplate to give you . you will be given nplate as an injection under the skin ( subcutaneous ) at least 1 hour before or 1 hour after taking nplate . the doctor will check your platelet counts regularly . regular blood samples will be taken to measure the number of your platelets and the amount of sugar in your blood .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection ( common ) and other signs of the respiratory tract ( common ). common : may affect up to 1 in every 10 people : bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness or the skin ( flushing ), blood clot in a lung artery (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening : do not store above 30 . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection each vial contains approximately 230 mg ( 1 . 5 ml ) of romiplopim . each single - dose glass vial of nplate 250 mg contains approximately 375 mg ( 2 . 0 ml ) romiplampim . additionally , each single dose contains approximately 125 mg ( 3 . 0 milliliter ) ( 4 . 0 micrograms ) ( 6 . 0 million iu ) ( 5 . 1 microgram ) ( 7 . 1 militer ) of the other active substance . - the other
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . using this medicine will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have kidney problems - have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor may decide to reduce your dose or stop treatment . if you think any of these apply to you , tell your doctor or pharmacist immediately . - have tightness of the chest , coughing , wheez
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to inhale the recommended dose is one inhalation once a day . you should inhale this medicine every day at the same time of the day . this will help you to remember to use it . however , if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor , pharmacist or nurse . how long to use to take this medicine your doctor will tell you how long you should continue to use this
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 23 . 5 microgram ) glycoprroniumbromide , equivalent to a 50 microgram / 0 . 5 millilitre glycopyronium . each delivered dose ( the delivered dose that leaves the mouthpiece of the inhaler ) provides a delivered dose of 44 microgram per kilogram of body weight when inhaled as recommended by your doctor . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms ( for example , schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the signs of bipolar disorder
do not take adasuve : - if you are allergic to loxapine or any of the other ingredients of adasve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking adsasuve if you : - have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or shortness of breath 25 - have neuroleptic malignant syndrome ( nms ), which may be symptoms of antipsychotic medicines . these symptoms include high fever , rigid muscles
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day . your doctor may increase your dose every 2 weeks to 4 . 5 mg depending on your condition . adasuve is for oral use . you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet as this may cause your condition to get worse . it is best to take the tablet with food , preferably in the morning , at about the same time each day . try to take it at the same
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking adasuve and see a doctor straight away if you notice any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include :
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . if you notice any visible signs of physical damage , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
always use adasuve exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . each single - dose inhaler delivers 5 mg of loxapine in the morning and delivers 4 . 5 mg in the evening . do not use more than your doctor tells you to use . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
azacitidine betapharm contains an anti - cancer agent which belongs to a group of medicines called cytokines . the active substance in this medicine is an antibiotic . it works by inhibiting the growth and spread of cells . what happens after you have given the medicine the medicine , you must continue to use it until your doctor tells you otherwise . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
you must not be given azacitidine betapharm : if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should tell your doctor if : you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor may ask you to have blood tests periodically during treatment . if you think you may be at an advanced stage of treatment , you should have a ' cycle ' to check that
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet of this medicine per day . your doctor will work out your dose based on your height and weight . you will usually be given one tablet once a day . if you do not respond well enough to this medicine , your doctor may increase your dose to one tablet every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given by subcutaneous injection ( sub
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these could be symptoms or signs of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . after reconstitution , the medicine must be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 45 minutes at 2 to 8 , unless dilution has taken place
what azacitidine betapharm contains - the active substance is azapitidine . each vial contains 100 milligrams ( mg ) of azacituidine . after reconstitution , 4 ml of water for injections should be used immediately . the reconstituted suspension contains 25 mg / ml . - the other ingredient is mannitol ( e421 ) ( see section 2 ). what you need to know before you start to use this medicine , check with your doctor or pharmacist if you are not sure what you have been asked to do . do not shake the vial vigorously as this may affect
the active substance in cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . if you do not respond normally to the medicine , you may not be able to take it . your doctor will test your affected organs to make sure that it is working properly . this medicine will be prescribed to you by a doctor who is experienced in the care of patients with this condition .
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called " moderate cyp2d6 inhibitors " ( e . g . quinidine , terbinafine ) 31 or moderatecyp3a inhibitors such as erythromycin or itraconazole . these medicines are used to improve your body ' s ability to absorb nutrients . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking cer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet twice a day with or without food . your doctor will tell you how many tablets to take . the amount of metaboliser to take depends on how much you are taking . the recommended daily dose is two tablets ( two tablets each day ) with food . swallow the tablets with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . take the tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations ( throat irritation ) heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin h
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the sleeve after exp . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of nominally adhered to the dietary recommendations of the world health organisation . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' important information about lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ) and indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution
this medicine contains the active substance in zoledronic acid hospira , zoledron acid , which belongs to a group of substances called bisphosphonates . zolingronic acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( a type of cancer that affects the primary site of the bone ). it reduces the amount of calcium in the blood in patients where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . if you are not sure if any of the above applies to you , talk to your doctor or pharmacist before you are given this medicine . warnings and precautions talk to the nuclear medicine doctor who is supervising the first course of treatment , if you : - are allergic ( hypersensitive ) to the active substance zoledron acid or another bisphosphonate ( the group of substances to which z
always use zoledronic acid hospira exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . bisphosphonates are given intravenously ( into a vein ) as ' iv ' administration . the recommended dose is one tablet once a day , with or without food , and at the same time each day . your doctor may prescribe a lower or higher dose depending on your condition and on how you respond to treatment . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most frequently reported side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ) low level of calcium in the blood ( uncommon ) uncommon : 100 cases of pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge , numbness or a feeling of heaviness or loosening of a tooth ) bone damage in the jaw ( osteonecrosis ) tell your doctor
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zolingronic acid . one vial contains 4 mg zoledron acid . - the other ingredients are monohydrate , mannitol ( e421 ), sodium citrate and water for injections ( see section 2 ' important information about some of the ingredients ') of the vial . what it looks like and contents of the pack ozoledronic acidic hospira is supplied as a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains a single vial of concentrate . not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat adults with a type of cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . this type of chemotherapy destroys nerve cells in the brain . this can lead to vomiting ( being sick ) and may be life - threatening . varuby works by blocking the action of these nerve cells , which can cause nausea and vomiting .
do not take varuby if you : are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). are taking an herbal medicine called st john ' s wort ( hypericum performatum ). are suffering from depression or difficulty sleeping ( see section 2 " warnings and precautions "). are taking this medicine 27 if you have severe liver or kidney problems . are taking certain medicines containing rifampicin ( used to treat tuberculosis and other infections ), carbamazepine ( used for epilepsy and nerve pain ), phenobarbital ( used in epilepsy ), enzalutamide (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . it is best to take the tablet at least 2 hours before or at the start of your chemotherapy cycle . your doctor will tell you how many days of chemotherapy you need to take . if you have sickness or if you feel sickness after taking this medicine , your doctor may tell you to take another tablet at the same
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately and receive appropriate treatment . other side effects include : very common : may affect more than 1 in 10 people : headache ; constipation ; feeling tired uncommon : may affects up to1 in 100 people
what varuby contains - the active substance is rolapitant . each tablet contains 90 milligrams . - the other ingredients in the tablet core are lactose monohydrate ( see section 2 under ' important information about lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . - film - coating contains : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . the colour of the tablet is blue . what varub
what enerzair breezhaler is the active substance in this medicine is indacaterol - glycopyrronium - mometasone furoate indacterol and glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this helps to open the airways wider and allows air to get in and out of the lungs more easily . what it is used for and why it has been prescribed for you by your doctor , pharmacist or nurse ? corticosteroids are used to reduce the swelling and
do not use enerzair breezhaler : - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems , diabetes , high blood sugar , seizures - have severe kidney problems , severe liver problems , or low level of potassium in your blood - have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale the medicine at the same time each day . it is important that you use enerzair breezhaler every day , as directed by your doctor . if your asthma does not go away or your symptoms get worse , your doctor may prescribe an alternative inhaler . how to use the active substance in this pack , you will find an inhaler and capsules that contain the medicine . the inhaler is for inhalation use only
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other possible side effects are listed below . common : may affect up to 1 in every 10 people : sore throat , runny nose , sudden difficulty breathing , feeling of tight
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of the combined active substances as indaconaterol and 63 microgram ( as hydrochlorothiazide ). each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 50 microgram / gram ( as aeropharmaceutical ) of both of these active substances , as well as 160 microgram per kilogram ( gbq ) of
clopidogrel acino pharma gmbh contains the active ingredient clopridogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombo - occlusion ). this process can also lead to the formation of a rare , but potentially life - threatening , condition called atherothrombosis . clopid
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopridogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are in any doubt at all ), tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking the tablet . take special care when you are taking cl
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual starting dose is one 75 mg tablet per day to be taken orally with or without food , and at the same time each day . your doctor may increase your dose to a maximum of two tablets per day depending on your condition and on the type of bleeding you are suffering from . take the tablet immediately after food , as described in the section at the end of this leaflet . do not take more than the recommended dose of clop
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) not known ( frequency cannot be estimated from the available data ): rare decrease of some blood cells ( signs of liver problems ) yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . accidental ingestion can cause damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil ( type a ) hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmágmbh looks like and contents of the pack
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are already taking medicines called ' antiretroviral medicines '. the active substances in delstrigo are doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which is also a nucleoside analogue reverse transcriptase inhibitor . nrti belongs to a group of medicines called tenofovir disoproxil , which are also known as ' oral anti - hiv medicines ' ( aids (' acquired immune deficiency syndrome '
do not take delstrigo : - if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist , or nurse before taking the following medicines : - carbamazepine or oxcarbazepine , phenobarbital and phenytoin ( medicines to prevent seizure ) - rifampicin or rifapentine ( medicines used to treat tuberculosis ) - st . john ' s wort ( hypericum perfor
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient to treat hiv infection for up to 1 month . your doctor may prescribe you certain medicines ( e . g . doravirine ) to help you remember to take these medicines . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking delstrigo and see a doctor immediately if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon : may affect up to 1 in 100 people : nightmares , depression , anxiety , irritability , confusion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicinal product does not require any special temperature storage conditions . the medicine should be kept in the bottle tightly closed in order to protect from moisture . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg of lamivudine ( equivalent to 245 mg of tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl feumarate . a coating material : carnauba wax e903 . film - coating : poly ( vinyl alcohol ), hyprom
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant in adults , adolescents and children aged 2 years and older . antidepressant medicines should not be used alone .
do not use spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . if you recently had a heart attack , which occurred within 6 weeks . a temporary increase in blood pressure can increase the risk of serious complications in these conditions . if any of these apply to you , tell your doctor before you are given this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using sprav
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use the spravato nasal spray the nasal spray device is contained in a separate sachet . each sachet contains 1 , 2 or 3 nasal spray devices . this means that you will need to use one spray device at least 4 times a day for the first 4 days of use . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . the recommended dose is one inhalation once a day . use in children and adolescents
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to noise in the mouth area spinning sensation ( vertigo ) vomiting nausea common : may affect up to 1 in every 10 people : feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes or ears a crawling feeling or being irritable panic attacks change in perception 37
what spravato contains - the active substance is esketamine . each nasal spray device contains an additional dose of esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is presented as a nasal spray solution . this medicine is a clear , colourless solution . it is available in a pack of one or more nasal spray devices and in multipacks comprising of 1 , 2 or 3 cartons of 6 nasal
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer has a change ( mutation ) in a gene responsible for producing melanoma cells . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . allergic reactions if allergic reactions occur while you are being treated , or after you have been given the medicine , contact your doctor or nurse immediately . if you experience any symptoms of an
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for up to 8 weeks . if you take more than 4 tablets a day , you may experience side effects . your doctor may reduce your dose or stop your treatment completely . taking zelboraf if you experience vomiting , do not take a double dose to make up for a forgotten tablet . take your tablet at the same time each day . it is best to take the tablet on an empty stomach . swallow the tablet whole with a glass of water
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation have been reported very rarely in cancer patients . if you experience any of the following , stop taking the medicine and contact your doctor immediately : radiation treatment tell your doctor or nurse straight away if you notice the following symptoms : skin rash , blistering , peeling or discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heart
your doctor , pharmacist or nurse knows how to store zelboraf properly . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - concipitate of vial contents ). - the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). printing ink : what zel
duoplavin contains the active substance clopidogrel , which is also known as acetylsalicylic acid ( saa ). it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , blood vessels relax , allowing blood to flow to them more easily . by reducing the amount of blood clots that can form ( a process called atherothrombosis ), duoplavan is taken by adults , adolescents and children ( 12 years of age and older ) to prevent
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you suffer from painful and / or inflammatory conditions of muscles or joints if you have a medical condition ( e . g . asthma , nasal discharge , runny nose , polyps [ a type of growth in the nose ]) if you currently have a risk of bleeding such as a stomach ulcer or bleeding within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you can take duoplavin with or without food . try to take your medicine at the same time each day . do not take more than your doctor tells you to . you may need to take it at different times of the day . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . take the tablet pack with you so that you can easily describe what you have taken . if
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any visible sign of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
duoplavin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel ( as acetylsalicylic acid ( aasa ), and 75 mg of its other ingredients , as adenovirus ( e553b ). the 75 mg active substances are : tablet core : cellulose , low substituted hydroxypropylcellulose ( e464 ), mannitol ( e421 ), macrogol 6000 ( e1521 ), microcrystalline cellulose ( i ) ( e460i ) ( lowest substituted hydrolysis ). tablet coating : hypromellose
the active substance of simbrinza is brinzolamide . it belongs to a group of medicines called carbonic anhydrase inhibitors . brimonidine titrate is a substance produced in the body that binds to receptors in the blood called alpha - 2 adrenergic receptor agonists . it works by reducing the amount of pressure within the eye , helping to reduce the pressure on the surface of the eye . the active substance in the medicine works by blocking the action of these receptors , making it easier for the blood to flow in and out of the eyes . it is used in adult patients ( aged 18 years and older
do not take simbrinza : if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given simbr
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid touching your eyes or eyes with your hands ( see step 1 and step 2 ). remove the cap and snap collar . before using the medicine , wash your fingers with soap and water . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a clean finger until there is a ' pocket ' between the eyelid and the eye . the drop will go in here . step 1
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . contact your doctor immediately if you experience extreme tiredness or dizziness . other side effects have been reported with simbrinza in combination with other medicines containing brinzolamide or brimonidine . common side effects ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if you use more simbrinza than you should do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each millilitre of suspension contains 10 milligrams ( millilitres ) of the active substance , as well as one milligram ( milliliter ), of which at the end of the 2 - ml vial , each ml of solution contains a single dose ( 300 micrograms ) of brinza . - the other ingredients are : benzalkonium chloride , propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tylox
filgrastim ratiopharm is a combination of two active substances , which contain a protein called escherichia coli . it belongs to a group of proteins called cytokines , and is very similar to a natural protein ( granulocyte - colony stimulating factor [ gf - csf ]) produced by your own body but has a very different structure . filgrasterim works by encouraging the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . the amount of white blood that your body produces will depend on how well fil
you must not be given filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may get a cough , fever and difficulty breathing . these may be signs of a pulmonary disorder ( see section " possible side effects "). if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder ( this may be a symptom of a spleen disorder ). your
always take filgrastim ratiopharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many tablets to take and how often you should take them . the usual dose is one tablet once a day . your doctor may change your dose depending on your condition and on how comfortable you feel . your dose will be adjusted by your doctor depending on how well you feel and how well your treatment is working for you . the recommended dose for adults , adolescents and children aged 14 years and above is the same as for some
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . possible side effects . your doctor will do regular blood tests before you start treatment and regularly while you are being treated , to check the number of neutrophils ( a type of white blood cells ). your blood will be tested regularly during treatment . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years . other medicines and
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the outer carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . after first opening : store in a refrigerator ( 2 to 8 ). do not freeze . keep the blister in the original carton in order to protect from light . don ' t remove the blister if it is cloudy or there are particles in it . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 million international units ( iu ). - the other ingredient ( s ) are : tablet core : aminotransferase ( e1201 ) filgrasteim ratiopharm 30 micrograms / 0 . 5 ml : each pre - filled syringe contains 30 milligrams ( international units ) of filgrateim . after dilution , the solution is clear and colourless . tablet coating : sodium hydroxide , glacial acetic acid , sorbit
what riluzole zentiva is and what it does it is a medicine that contains the active substance rosuvastavir . it is used to treat adults with amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells in the muscles are damaged , leading to weakness , muscle waste and paralysis . this causes the destruction of nerve cells . in patients with motor nerveone disease there may be too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilanuzolezentiva works by reducing the amount of glutamate in the nervous system . this will
you must not be given riluzole zentiva : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you have any liver disease or increased blood levels of some enzymes of the liver called transaminases . if you think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before you are given this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before you receive this medicine if you develop any liver problems such as yellowing of your skin or the whites of your eyes ( jaundice ), itching ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth at about the same time each day . if you take more riluzole zentiva than you should if you accidentally take too many tablets , contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible , show the doctor your pack of tablets . do not take a double dose to make up for a forgotten tablet . you should not take more tablets than your doctor tells you to . if
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva . this may be due to a decrease in the number of white blood cells . your doctor will take a blood sample to check for this and may adjust the dose if necessary . if you notice any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood
what riluzole zentiva contains - the active substance is rilanuzole . - the other ingredients are : - core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460 ) - coating : ahydrous colloidal silica , magnesium stearate - printing ink : croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ) not all of the ingredients in the tablet core may be present in the film - coating . what rilsuzole xentiva looks like and contents of the pack the tablets are
emgality contains the active substance galcanezumab . it is a medicine that blocks the activity of a protein called calcitonin gene , which is involved in migraine . increased levels of cgrp in the blood can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and above who have experienced at least one or more of their previous migraines . your doctor has determined the frequency of migraine headache associated with each type of migraine and to improve your quality of life .
you must not be given emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases can occur , especially in patients with an increased risk of allergic reactions emegality may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see your doctor immediately if you experience such signs or serious side effects as described in section 4 . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years .
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg / m2 body surface ( subcutaneous injection ). your doctor may decide to increase the dose depending on your response . your doctor will calculate your dose based on your body surface area ( surface area ) and will tell you how many days you should continue to use it . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects ( may affect more than 1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after reconstitution , the product may be stored for up to 8 days at a temperature of up to 7 and away from direct heat or direct light . once reconstituted , emgality should be used within 30 days or disposed of . if not used immediately , in - use storage times and conditions prior
what emgality contains - the active substance is galcanezumab . one ml of each pre - filled pen contains 120 mg ( 10 mg / ml ) galcanesumab in 1 ml of solution . - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what emgon looks like and contents of the pack emgonality is presented as a solution for injection in a clear glass syringe . the solution is clear to slightly opalescent and colourless to pale yellow . the syringe
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and clogged with blood clots . it may be given to you by your doctor or nurse , or by medicines you have received prior to a stem cell transplantation . your doctor will tell you how many days of treatment you need . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - are taking other medicines to prevent blood clots ( tissue plasminogen activator warnings ) - are using medicine to prevent bleeding ( e . g . heavy bleeding when you are having a blood transfusion or surgery ) - have problems with blood circulation - have a constant blood pressure ( see section 1 " important information about some of the medicines you may take ") -
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce the dose to a single dose . children and adolescents do not give this medicine to children less than 18 years of age . if you have any further questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor or
like all medicines , defitelio can cause side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist immediately . very common ( may affect more than 1 in 10 people ): low blood pressure . this may affect up to 1 in every 10 people . bleeding in general bleeding , including the nose bleeding , the brain bleeding , and the gut vomiting blood bleeding from the lungs bleeding from blood in the urine , the mouth bleeding , or the skin coagulopathy ( disturbance in blood clotting
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion storage should be completed within 24 hours of dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at 2 - 8 , unless dilution has taken place in controlled and validated aseptic conditions . please inform your healthcare professional if you notice that the solution
what defitelio contains - the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defabrotide ( as an add - on ). each ml solution contains 80 mg / ml ( 0 . 25 %) of the original amount of defibotide . - the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defitelsio contains sodium " for further information . solvent vial : powder for concentrate for solution for infusion . what def
daklinza contains the active ingredient daclatasvir , which is used to treat hepatitis c , an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by blocking two different proteins that are involved in the blocking of both of these proteins , called thrombocytopenia and ciprofloxacin . by blocking both of the three proteins , this medicine stops both of them from coming into contact with each other and stops them from infecting each other . this will help to stop hepatitis c from spreading to other parts of the body . it will also help to reduce
do not take daklinza if : you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) you are taking by mouth the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics to treat tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum perforatum )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or chew the tablet as it may have an unpleasant taste . your doctor will tell you how many tablets to take . if you need to take some other medicines , your doctor may tell you to take a different dose . it is important to keep following the instructions given to you by your doctor , pharmacist or nurse so that you can easily describe what you have taken . if
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common : common : may affect up to 1 in every 10 people difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles have also been reported . if you have been treated with either of these active substances , you may experience decreases in the number of red blood cells ( anaemia
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ) and yellow iron oxide ( e172 ) 51 film - coating : tablet ink : d
proquad is a vaccine to protect against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the diseases that cause mumps and rubella . these are usually caused by the same types of varicellis viruses . the antibodies help to prevent diseases caused by these viruses . how proquad works proquad causes the body to produce its own protection ( antibodies ) against several different types of diseases . these viruses are then grown in chicken eggs . proquad is given to individuals 9
do not receive proquad : if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( for example , treatment with medications that suppress your immune system , e . g . low - dose corticosteroid therapy , asthma or replacement therapy ). if you suffer from a weakened immune system due to a disease ( including aids ), congenital or hereditary immunodeficiency ( lack of immune competence ) or active untreated tuberculosis . if you
proquad is given by injection into a muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the muscle or thigh area or into the upper arm area . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given . injecting into the skin may increase the risk of bleeding or damage to the muscle . proquad will be injected into a blood vessel . your doctor or nurse will give you proquad as an injection into the blood . children and adolescents proquad is not recommended for use in children or adolescents aged 9 months to less than 12 years
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . you should contact your doctor immediately if you experience signs of an allergic reaction . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) and a fever . rare : may affect 1 in 1 , 000 people : bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). if any of the side effects gets serious , stop using proquad and tell your doctor
what proquad contains - the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain 3 .00 mg varicella virus3 , merck strain ( 3 . 99 mg mrc ). - the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 what proquad looks like and contents of the
jylamvo is a substance in the body known as an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . it works by reducing the activity of the immune system ( the body ' s natural defences ). it is used for the treatment of rheumatic and skin diseases such as active rheumatoid arthritis , polyarthritic forms of joints , severe juvenile idiopathic arthritis ( jia ) in adults and children 3 years of age and older . it can also be used in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe
do not use jylamvo : if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment or a liver impairment if you suffer from blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia , significant anaemia ) 34 if your body has a weakened immune system and you have ever had a serious infection such as tuberculosis , hiv , ulcers in the stomach or intestines , an inflammation of the mucous membrane of the mouth or mouth ulcers if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will discuss these with you and will adjust the dose and duration of the treatment . rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis if you have any of the above conditions , your doctor may suggest that your doctor give you a lower dose ( 0 . 5 mg / m2 ) once a week , as part of a long - term treatment . how j
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching all over your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after dilution . in the event of accidental spillage , chemical and physical in - use stability has been demonstrated for 3 hours prior to administration . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains ∑ the active substance is methotrexate . each ml of solution contains 2 mg / 0 . 5 mg of metotrexate ∑ each vial contains macrogol ( equivalent to 400 mg ), glycerol ( e420 ), orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzzoate , citric acid , tri - sodium citrate , purified water . ∑ see section 2 " sodium content " for further information about some of the ingredients of this medicine ( listed in section 6 ).
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten . this makes breathing difficult . using this medicine reduces the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . if you use this medicine regularly , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from kidney problems . if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . tell your doctor or nurse immediately if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the product . these may be signs of bronchospasm ( difficulties in breathing or swallowing
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine is for inhalation use only . if you have the impression that the effect of the medicine is too strong or too weak , talk to your doctor . your doctor may increase your dose to a maximum of 24 inhalation per day ( equivalent to 75 inhalations per day ). do not stop using this medicine unless your doctor tells you to . how to use enurev breezhaler this
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst or hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness . signs of allergic reaction may include swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 0 . 5 milligrams ) glycoprroniumbromide , equivalent to a 50 microgram ( milligram ) dose . - the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 44 microgram / gsi ( 1 . 0 milliliter ). - the other ingredient in the inhalation powder is lactose monohydrate ( see section 2 ), magnesium stearate ( e470b ) and water for injections
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the protein , riximyo slows down the rate of growth and the progression of the disease . your doctor will test your body ' s immune system to make sure that it is working properly . a ) non - hodgkin ' s lymphoma is a disease of the lymph tissue ( part of the immune system ) that affects a type
do not use riximyo : - if you are allergic to rituximab , other proteins derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have : - a severe active infection at the moment - a weak immune system - severe heart failure - severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ) if any of these apply to you , tell your doctor
you will be given riximyo under the supervision of a doctor who is experienced in the use of this treatment . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may decide to reduce your dose . your doctor will decide if you need to take a lower dose or stop treatment altogether . you will only be given a drip ( intra - venous infusion ) into a vein . medicines given before each riximusyo administration you will also be given other medicines ( premedication ) to reduce the risk
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab when reconstituted as recommended . after reconstitution with 10 ml water for injections , each 50 ml ampoule contains 500 mg ( 10 mg / ml ). - the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 for further information on some of the ingredients of this medicine ). colourless to slightly yellowish solution for infusion . pack sizes of 2 , 3 ,
topotecan actavis contains the active substance topotecaan . it is used to treat the following conditions : - small cell lung cancer that has come back after chemotherapy - advanced cervical cancer that cannot be treated by surgery or radiotherapy . in this case topotecen actavis treatment is combined with medicines containing cisplatin .
do not use topotecan actavis : - if you are allergic to topoteecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you are breast - feeding . your blood cell counts may be too low . your doctor may decide to reduce your dose , or temporarily stop your treatment , if this applies to you . - you have or have had any kidney problems . if you think any of these apply to you , tell your doctor or pharmacist before you start treatment with topot
always use topotecan actavis exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will base the dose on the disease and will carry out blood tests before you start treatment . the recommended dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will be repeated every three weeks . for cervical cancer , the usual dose for the first three days is 0 . 75 mg per sq metre of surface area twice daily for 3 days . you will usually only be given this treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects stop taking topotecan actavis and tell your doctor straight away if you notice any of the following serious effects : infections ( very common , may affect more than 1 in 10 people ): fever . this may be a sign of your general condition ( local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea ). bowel inflammation ( neutropenic colitis ) has been reported in patients treated with the combined combination of the two active substances , and has severely reduced your ability to fight infections .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . the drug product solution for reconstitution / dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 and from 2 to 8 when refrigerated . from a microbiological point of view , the product solution should be used immediately . dilution in solutions for infusion ( nacl 0 . 9 %) glucose 5 mg / ml solution for
what topotecan actavis contains - the active substance is topotecaan . each vial contains 1 mg or 4 mg topside ( as hydrochloride ). after reconstitution with 1 ml of water for injection , 1 mg / ml ( 0 . 5 %) topside is clear and colourless to pale yellow . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see section 2 under ' contents of the pack '), grey bromobutylic stopper , aluminium seals with plastic flip - off caps and a
the active substance in this medicine is rivastigmine hexal , which belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). by blocking the activity of these enzymes , the medicine helps to increase the levels of oxygen in the blood . this helps to reduce the amount of acetylecholine in the body , and reduces the effects of alz
you must not be given rivastigmine hexal : if you are allergic to dulutrombazine , the active substance in this medicine , or any of the other ingredients of this medicine ( listed in section 6 ). if you have had a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before being given this medicine . tell your doctor if : you have a history of irregular or slow heartbeat you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may gradually increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg per kilogram of body weight each day . you should continue taking this medicine until your doctor tells you otherwise . if you have not taken your medicine for more than three days , do not take the next dose until you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with your medicine : very common ( may affect more than 1 in 10 people ): feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common : may affect up to 1 in every 10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon : may effect up to1 in every 100 people depression difficulty in sleeping fainting or accidentally falling changes in how well
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains - the active substance is 64 mg / ml . - the other ingredients ( excipients ) are : - capsule content : : capsule contents : capsule shell : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin - printing ink : yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ) and shellac . - each riobitrix hexal 1 . 5 mg film - coated tablet is engraved with the code " ri1 " on one side and " 1 .
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adult patients with kidney cancer ( renal cell carcinoma ) or liver cancer that has not responded to a specific anticancer medicine containing sorafenib . cabometyx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , it can prevent high amounts in cancer cells from growing and dividing . this medicine is used in adults .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabomety if you : - have high blood pressure - have or have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in or around a blood valve wall - have diarrhoea - have recently had significant bleeding from surgery or within the last month - have had surgical procedures or dental surgery - have inflammatory bowel disease - have crohn '
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . this medicine is for oral use . swallow the tablet whole with a glass of water . you can take cabometyx with or without food . try to take your daily dose at about the same time each day . do not stop your treatment unless your doctor tells you to . this will help you to get the best results and reduce the risk of serious side effects . duration of treatment your doctor will tell you how long you should continue to keep taking cabomet
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx : your doctor may prescribe other medicines to help control your side effects . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea , feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood ,
what cabometyx contains - the active substances are cabozantinib ( s ) and malate . each tablet contains either 20 mg / 40 mg cabozatinib , or 40 mg / 60 mg of cabozutinib . - the other ingredients are microcrystalline cellulose ( e460 ), lactose anhydrous , hydroxypropyl cellulose , croscarmellose sodium ( e468 ), colloidal silicon dioxide anhydrated , magnesium stearate ( e470b ). see section 2 for lactose content . - film coating : hypromellose , titanium dioxide (
pemetrexed hospira is a medicine used in the treatment of cancer . it is used in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemetrexED hospira will also be given to you by your doctor as an injection into the lung . your doctor will decide on the initial treatment for you . if you have lung cancer that has come back after a long and steady treatment of your disease , your doctor may decide to give you
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before breast - feeding , during or after treatment . if you have recently received or might receive any other medicine , including a vaccine against yellow fever , please tell your doctor before you are given this medicine . you may be more at risk of having problems with your kidneys if any of these apply to you ( or you are not sure ), talk to a doctor or pharmacist before you
the recommended dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out your surface area of the body . your doctor will work out the right dose for you based on this body surface area and will adjust your dose and duration of treatment depending on your blood cell counts and on your general condition . the doctor will also calculate the dose you should receive based on your weight and the results of your clinical trials . when prepared as directed , chemical and physical in - use stability has been demonstrated for 9 hours at a concentration of 9 mg /
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever or infection with a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . - chest pain with a fast heart rate . - pain , redness , swelling or sores in your mouth ( signs of allergic reaction ). - skin rash , often with burning or prickling sensation . - fever . skin reactions may be serious and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of infusion solutions of pemetrexed were demonstrated for 24 hours at 2ºc - 8ºc . from a microbiological point of view , the product is a sterile , colourless to pale yellow solution . if not used immediately , in -
what pemetrexed hospira contains the active substance is pemetreepentahydrate . one vial ( 0 . 5 ml ) contains 100 milligrams ( millilitres ) of pemphrexed ( as pexyrexed disodium hemipentahhydrate ). one ampoule ( 500 micrograms ) contains 500 milligram ( millipetrexed [ per 1 , 000 millilitre ]). the other ingredient ( s ) ( excipients ) ( e . g ., pemetraconazole ) are water for injections . see section 2 "
ganfort contains two active substances called bimatoprost and timolol , which work together to reduce pressure in the eye . both of these active substances are used to treat glaucoma . ganfort belongs to a group of medicines called prostamides . it works by interfering with a prostaglandin analogue ( analogue ) that is present at the back of the eye and helps to lower the amount of pressure in your eye . it is used in adults , adolescents , children and infants aged one month and above who have already received medicines called beta - blockers . the eye is a clear , watery
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( e . g . wheeziness , difficulty in breathing , or long - standing cough ) warnings and precautions talk to your doctor or pharmacist before using this medicine if you suffer from coronary heart disease ( symptoms include chest pain , tightness , breathlessness , choking , heart failure ), low blood pressure 44 if you
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in your eye once a day at the start of treatment . keep the bottle tightly closed in order to protect from moisture . do not put the bottle close to your neck . 5 . gently squeeze the bottle . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid until there is a small pocket . 3 . put your eye back in place . continue treatment for as long as instructed by your doctor . 4 . close the lid of your
like all medicines , ganfort can cause side effects , although not everybody gets them . stop using the drops and see a doctor straight away if you notice any of the following serious side effects after taking a single - dose ( or multi - dose ). very common side effects ( may affect more than 1 in 10 people ): - the eye redness . uncommon side effects these may affect up to 1 in 9 people : - sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the eye ( inflammation ), difficulty in seeing clearly , redness , itching of
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice that the solution is not clear or contains particles , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each vial contains 0 . 3 mg of timolol ( equivalent to 5 mg per ml ). - the other ingredients ( excipients ) are aminotransferase ( a type of medicine ), dimethyl sulfonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid , and sodium hydroxide . the solvent is clear to slightly yellow and colourless to pale yellow in the eye . what gansfort
gefitinib mylan contains the active substance gefitinib . it blocks the activity of a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells and is present in large amounts in the blood and other tissues of the lung .
you must not be given gefitinib mylan : if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have or have had any other lung problems . some lung problems can be serious and your doctor may need to adjust or stop your dose of the medicine . this is particularly important if you have had or have ever had problems with your liver . if any of these apply to you , tell your doctor straight away . children and adolescents do not give g
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take antacids on an empty stomach ( see section 2 " gefitinib mylan contains lactose "). try to take the tablet at about the same time each day . if you have trouble swallowing the tablet whole , talk to your doctor . do not take any other liquids until your doctor tells you otherwise . the tablet can be taken with or without food . the maximum recommended dose for adults is 20 mg once a
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease ' ( i . e . uncommon , may affect up to 1 in 100 people ). gefitinib may cause severe skin reactions
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefginib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ) ( type k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol ( e1203 ), macrogol 4000 ( e1521 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide e172 . what g
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by lack of red blood blood cell transfusions . your doctor has prescribed reblozell for you to treat anaemia in patients with mds who do not respond adequately or who cannot be treated in the long term , and who have not responded adequately or cannot receive red
do not take reblozyl : if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy , breast - feeding and fertility ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have thalassaemia ( a condition where the spleen removed from the body ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot , or if preventive measures ( including medicines ) have been put in place to prevent the occurrence of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before and during your treatment with reblozyl . the recommended dose is one injection under the skin ( subcutaneously ). the dose depends on how much you weigh and how often you need to have the injections . the usual starting dose is 1 . 0 mg for each kilogram of body weight . this dose may be increased or decreased depending on your blood pressure . use in children and adolescents the recommended starting dose for children with myelodysplastic syndrom
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in other parts of the body , blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions including rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for a single period of up to 25 days when stored at 2 8 . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg ( 10 mg / ml ) luspaterscept . after reconstitution with each mlof solution , each ml contains 50 mg or 100 mg ( 5 mg / m2 ) of luspisercept . - the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( ( to adjust ph adjustment ). see section " important information about some of the ingredients of rebl
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor that works by blocking the activity of a protein in the body called alpha or interleukin - 2 , which is involved in the growth and spread of cancer cells . it works by stopping the growth of new blood vessels in patients with advanced kidney cancer who have not previously tried other treatments ( alpha or intrathecogen - 2 ) which have not helped to stop your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are breast - feeding . you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used to treat depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have high blood pressure . your doctor will check your blood pressure before you start taking a medicine . if you are not sure if any of these applies to you , ask your doctor or pharmacist
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of fotivda is 1340 mg twice a day ( 21 mg capsules and 7 mg capsules ) taken once a day in the morning and once in the evening , at about the same time each day . your doctor will tell you how many capsules to take and for how long , depending on how long you need to take them . the recommended daily dose is 1 capsule ( 3 times a day ). your doctor may increase your dose to 4 capsules ( 6 times a
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience any of the following symptoms : severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely while you are taking fotivda . you may need to stop taking this medicine for a short time , or stop taking it altogether . if your high blood
what fotivda contains - the active substance is tivozanib . each hard capsule contains 890 mg of tivuzanib ( as besilate ). - the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ) and propylene glycol ( e1520 ) as solvent for strong ammonia solution . capsule shell : titanium dioxide e171 , tartrazine aluminium lake ( e129 ) and shellac . printing ink : ink : shellac , printing ink ( shellac ), printing ink containing strong ammonia
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of the activity of the immune system ( the body ' s natural defence system ). both of these active substances are active in the treatment of hiv . each of the active substances is given orally once a day as an anti - hiv medicine called a nucleoside reverse transcriptase inhibitor ( nrti ). the other active substance is tenofovir disoproxil . each active ingredient is an
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . during treatment , you should tell your doctor if you have taken any medicine containing any of these active substances . your doctor may also monitor your kidney function while you are taking these medicines . alfuzosin ( used to treat an enlarged prostate
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet once daily by mouth . swallow the tablet whole with a glass of water . you can take your tablet with or without food . your doctor may change the dose of your medicine depending on how you respond to the treatment . if you take medicines called oral supplements ( such as antacids or laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ), take the tablet at least 4 hours before
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the disease itself or by the medicines being used to treat it . serious side effects tell your doctor immediately : lactic acidosis ( excess l
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each tablet contains 150 micrograms ( as tablet core ). each film - coated tablet contains 300 microgram s ( as tablets core ). - the other ingredients are tablet core : amitriptyline ( e1201 ), emmettabine ( e904 ), 245 microgram ( 4 tablets core ) ten ofovir disproxil pregelatinised , 300 milligrams ( 6 tablets core ), tenofove
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . you have been shown to experience a recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded or has recurred in some cases after
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include a rash , itching , a swollen face , swollen lips and shortness of breath . if you have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given zypyxa . some patients with dementia
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual dose of zyprexa tablets is one tablet once a day . your doctor may increase your dose to one tablet twice a day ( morning and evening ). your doctor will tell you how many tablets to take and how long you should continue to take them . the dose may be increased by up to 5 mg or by 20 mg depending on your symptoms . how to take take your tablets at the same time each day . swallow the tablet whole with a glass of water . you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue . this may be a sign of blood clots in the veins . this side effect has been reported uncommonly ( may affect upto 1 in 100 people ) in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . zyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
zyprexa contains the active substance is olanzapine . each zyprexa tablet contains 2 . 5 mg / 5 mg , 7 . 5mg / 10 mg , 15 mg / 20 mg . the other ingredients are : tablet core : lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), carnauba wax . see the end of this leaflet for important information about the different yypxa tablet strengths . what zy
what prolia is prolia contains denosumab , which is a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen in the blood , which makes bones thin and fragile . osteopORosis is caused by the lack of female sex hormones , such as testosterone , and glucocorticoids , which are used to treat osteop
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolia if : you have a skin infection with symptoms such as a swollen , red area of skin on one side of your leg that feels hot and tender ( cellulitis ) you have symptoms of fever . these symptoms may be due to an allergy to latex . the needle in the pre - filled syringe contains a derivative of latex
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . one pre - filled syringe contains 60 ml of solution for injection , which should be given within 6 hours . it can be given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . if you use more prolia than you should if you think you may have injected too much prolia , tell your doctor , pharmacist or nurse straight away . you may also be asked to wear stickers to remind you to take calcium and vitamin
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you notice any of the following skin infections ( cellulitis ). these symptoms may be due to prolia : swollen , red area of skin ( usually in the leg ), which feels hot and tender . these may be symptoms of fever ( see section " warnings and precautions "). if any of these symptoms occur , stop taking the tablet and contact your doctor immediately . pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of your pre - filled syringe after exp . this medicine does not require any special storage conditions . after first opening , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 days at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . however , if the injection has been
what prolia contains - the active substance is denosumab . each 1 ml pre - filled syringe contains 60 mg of denosumaab at a concentration of 60 mg / ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear , colourless to slightly yellow solution for injection ( injection ) in a clear to slightly opalescent or clear to pale brown to pale yellow solution . it is supplied in a pre -
aimirix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b infection . the hepatitis a virus causes the liver to become swollen and inflamed , which can be caused by the virus . the virus infects faeces , serum or saliva . symptoms occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches and pains , feel very tired , dark urine , palefaeces or yellowish skin or eyes ( jaundice ). the severity and type of symptoms vary from person to person . all symptoms can occur
you must not be given ambirix - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . tell your doctor straight away if you get any of these signs . you should not receive any vaccine against hepatitis a or hepatitis b diseases . if you have a severe infection with a high temperature , the vaccine should be given at the same time as a minor infection such as a cold . warnings and precautions talk to your doctor , pharmacist or nurse before
always use ambirix exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will give you the injection into a muscle ( usually in the upper arm ) by a doctor or nurse . you will usually receive one injection ( intravenously ) into a vein . the injection will usually be given into the thigh muscle . you may receive a total of two injections . the injections should be given within 12 months of the first injection . the second injection can be given between 6 and 12 months after the first . if you have any further questions on the use of this product , ask
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where the
what ambirix contains 26 the active substance is hepatitis a virus . each 1 ml pre - filled syringe contains 720 micrograms of elisa units ( equivalent to hepatitis b surface antigen ). the other ingredients are : 20 % human diploid ( mrc ), cells , aluminium hydroxide ( hydrated 0 . 05 %), saccharomyces cerevisiae , aluminium phosphate ( 0 . 4 %), sodium chloride , and water for injections ( see end of section 2 ). what Ambirix looks like and contents of the pack suspension for injection ( injection ) is a white , slightly milky liquid . amb
besero is a meningococcal group b vaccine . bexsero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). your doctor or nurse will administer the vaccine to you to help prevent the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are vaccinated . if you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . if any of these apply to you , tell your doctor straight away . vaccination should not be given if you suffer from haemophilia or any other problem that may prevent your blood from clotting properly . blood thinners ( antico
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection ( 5 ml ) in the muscle of the thigh or upper arm . your doctor will give you two injections ( 2 or 5 ml ). you will receive three injections of the vaccine followed by an additional injection ( booster ). the first injection should be given at least 2 hours apart . the interval between injections should not exceed 1 month . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . children and adolescents the interval
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the area of injection site hardness at the place of injection injection site the following side effects have been reported with this vaccine : common : may affect up to 1 in every 10 people : fever , loss of appetite , severe injection site tenderness ,
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each vial contains 1 , 2 , 3 or 50 micrograms of reconstituted dna technology . the other ingredients ( excipients ) are recombinant non - natalised group b fhbp fusion protein ( see end of section 2 ) and group b nov ( e . coli cells ). the vials contain a total protein of 1 mg , 2 mg , 3 mg , 4 mg , 5 mg , 6 mg , 7 mg , 8 mg , 10 mg
what nitisinone mdk is and what it is used for this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . due to this disease your body cannot break down the amino acid tyrosine ( amino acids are substances that are naturally present in the body ) and they accumulate in the cells of your body . your doctor will tell you how long you should continue to take the medicine and how long it will take to break down and remove the harmful substances . this medicine will help to reduce the amount and amount of ty
do not take nitisinone mdk - if you are allergic to any of the active substances ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding and fertility you must tell your doctor if you think you may be pregnant or are planning to have a baby . your doctor will check your eyes regularly during and up to six months after you start taking nitis inone treatment . if you develop red eyes or any other problems with your eyes contact your doctor immediately . you may also need an eye examination . eye problems due to inadequate dietary control
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended starting dose is 1 mg for every kg of body weight . this dose may be increased to a maximum of 20 mg for this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your doctor immediately . if possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . from a microbiological point of view , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nisinone . each hard capsule contains a white to off - white powder . each capsule contains either 2 mg or 2 mg of ninone ( as besilate ). each capsule is printed with the number 5 on the body . - the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ) and shellac glaze ( e1520 ) to help protect the hard capsules from light . see the end of this leaflet for further information on the ingredients used to make the capsules . what n
docetaxel accord will be given to you in a hospital or clinic under the supervision of a doctor who is experienced in the use of anti - cancer medicines called taxoids . your doctor will decide on the appropriate dose , depending on your condition and on the type of breast cancer you have . the usual dose is one tablet per day . if you have breast cancer , lung cancer or non - small cell lung cancer , prostate cancer , gastric cancer or head and neck cancer : - the recommended dose is two tablets per day , with each other debossed with ' m ' on one side and ' c ' on the
do not use docetaxel accord : - if you are allergic ( hypersensitive ) to any of the active substances ( listed in section 6 ) - if your number of white blood cells is too low − if you suffer from a severe liver disease . warnings and precautions before you are given this medicine , you will have blood tests to check that you have enough blood cells and that your liver is working properly ( see section 4 ). during the first few days after you are treated , you may experience some of the following : - very common ( may affect more than 1 in 10 people ) - low numbers of a type of white
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxell accord is given as an infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . based on the results of your blood tests , your doctor may change the dose and frequency of dosing depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of the following events may occur during the administration and after the administration of docelaxel with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . after dilution , the medicine should be transferred from the infusion bag and used within 6 hours ( corresponding to 25 hours of infusion ). the infusion solution should be used immediately . non - pvc bags may be stored for up to 48 hours at 2 to 8 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of
what docetaxel accord concentrate and solvent for solution for infusion each ml of concentrate contains 20 micrograms ( 0 . 5 millilitres ). the other ingredients ( excipients ) in the concentrate are : one vial of 20 microlitres ( 1 ml concentrate contents ) and one pectin ( 20 milligrams ( 1 milliliter ) in each millilitre ( ml ) of solution for injection . each pctin ( 4 ml concentrate contains an 80 microgram ) of docelaxel . each 8 ml ampoule ( 2 ml ) contains an additional 160 microgram of docet
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . what intuniv is used for this medicine is used to treat impulsive , hyperactive adults who are not able to resist the impulse , drive or temptation to carry out certain activities that could harm themselves or others . your child ' s doctor has prescribed this medicine for the treatment of ' attention deficit hyperactivity disorder ' ( adhd ) in adults whose current stimulant medication is not controlling adhd symptoms . the medicine should be used together with a treatment programme consisting of psychological therapy ,
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure , heart problems , or heart problems . tell your doctor if you fainted recently or have ever had thoughts or feelings of suicide , or any other psychiatric conditions ( withdrawal symptoms ). increased heart rate ( especially if your heart is pumping more blood than usual ) has been reported in patients with highblood pressure . if any of these apply to you ( or you are not sure
your treatment should be initiated under the supervision of a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will determine the dose that is right for you . the dose will depend on your condition and your response to your treatment . the usual starting dose is 1 tablet a day for 1 week . depending on how you respond to treatment , your doctor may increase your dose to 0 . 05 mg / 0 . 12 mg / kg of bodyweight once a
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and seek medical help immediately . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). your doctor will monitor you for side effects during treatment and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister pack after exp . this medicine does not require any special temperature storage conditions . keep the tablets in the original blister pack in order to protect from moisture .
what intuniv contains - the active substance is guanfacine hydrochloride . 1 mg prolonged - release tablets : each prolonged release tablet contains either 1 mg , 2 mg or 3 mg of guanfuine ( see end of section 3 for further information ), 3 mg , 4 mg , and 5 mg guanFacine . - the other ingredients are : tablet core : hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type a ( type a , microcrystalline cellulose ), silica colloidal an
ecalta contains the active substance anidulafungin . it is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida ( echinocandins ). these medicines prevent serious fungal infections by preventing them from growing . ecalta works by weakening the fungal cell walls . this means that the cells can no longer grow and help to protect you from the infection . it also prevents the growth and spread of invasive candida by blocking the growth of
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may need to monitor your liver function . if you have liver problems , your treatment may be interrupted or you may be given anaesthetics during or after your treatment . if any of these apply to you ( or you are not sure ), tell your doctor or nurse immediately . warnings and
always use ecalta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the treatment will be started by a doctor or nurse who is experienced in the use of this type of medicine . the recommended starting dose is 200 mg or 100 mg once a day . your doctor will work out the right dose for you . children and adolescents ( aged 1 year to 18 years ) the recommended dose is 3 . 0 mg , 200 mg , 1 . 5 mg and 100 mg per day . depending on the patient ' s weight , your doctor may increase or decrease the dose of ecalt
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : potentially life - threatening allergic reactions : difficulty breathing or wheezing if you have an existing rash , stop taking ecalta and seek medical help immediately if you experience any of these serious or potentially life threatening effects : - convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheeezing , coughing or difficulty of breathing other side effects very common side effects ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special temperature storage conditions . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . the infusion solution may be stored at room temperature ( up to 25 ) for a single period of up to 48
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 micrograms ( 23 milligrams ) of an idulafugin . - the other ingredients are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 . see the end of this leaflet for further information about some of the ingredients of the powder and solvent for solvent for concentrate for solution for infusion . do not shake the vial vigorously as this may affect its action .
adenovi contains the active substance rurioctocog alfa pegol , which is produced by recombinant dna technology without addition of any human coagulation factor viii ( i . e ., not all human blood is made in the same way ). it belongs to a group of proteins called cytokines , and is used to form clots and stop bleedings in patients with haemophilia a and b . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older and in children of all ages and in adolescents who are not able to produce factor
do not use adynovi if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using adynov : if you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction to any ingredient in this medicine ), or if you notice any unusual signs of allergic reactions such as rash 95 , hives , wheals , generalised itching , swelling of
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the most appropriate dose for you . the dose you receive will depend on your condition and on the type of bleeding that you are suffering from . the doctor will determine the dose that is appropriate for you and will prescribe the replacement therapy that is best suited to you . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . dosage and prevention of bleeding the recommended dose for adults of the age of 40 and older is 50 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . if sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment may be required . patients receiving previous treatment with factor viii ( more than 150 days of treatment ) inhibitor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the container in the outer carton in order to protect from light . the powder vial may be kept at room temperature ( up to 30 ) for a single period of up to 3 months . after this period , this medicine must be used within 3 months or discarded . if it has been stored for more than 3 months , the product must be returned to the refrigerator and
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu ( corresponding to a concentration of 1 . 5 micrograms / ml , i . e . a concentration equal to 0 . 5 million iu / ml ). - the other ingredients are : sterilised water , water for injections , mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride di
rekovelle contains follitropin delta , a follicle stimulating hormone ( fsh ), which belongs to a group of hormones called gonadotropins . fsh is involved in the development of female fertility in women undergoing assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . it stimulates the ovaries to produce many egg sacs .
do not use this medicine if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before using rekovelle . warnings and precautions you should tell your doctor if : you have or have had your fertility problems before . you are allergic to follicle stimulating hormone ( fsh ). you have enlarged ovaries , cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), malformations of the sexual organs ( see section " pregnancy and breast - feeding "). you have fibroids of the uterus (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you at the start of your first treatment cycle . your doctor will prescribe a type of anti - müllerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on the amount of medicine in your blood , your body weight , and the results of a blood sample taken during the last 12 months of treatment . how much and how often to use the dose the doctor will base the dose on your body
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones ( infertility ) this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea may be the most common side effect in women after receiving rekovelle , but it may also be a symptom
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . rekovelle may be stored at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months at 28 to 25 . during the treatment any
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 milligrams of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 million international units ( iu ), corresponding to approximately 1 . 5 micrograms ( 23 . 3 microgram ) of follnitropin delta in each millilitere of solution ). - the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dod
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation contains either one of the following active substances : - ellipta 92 micrograms ( 0 . 5 milligrams ) of the two active substances , - flavonoids ( e . g ., rifampicin ) of each metered dose . each 22 microgram inhalation provides a delivered dose ( the dose that leaves the airways ) of both of the active substances . each 92 / 22 subtype of chronic obstructive pulmonary disease ( copd ) is defined as a condition
do not use ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ellipta . ellipta has not been studied in patients with liver disease . it is not known whether ellipta causes side effects . if you have moderate or severe liver disease , your doctor may prescribe the lower strength of revinty ellipta 92 / 22 mg . tell your doctor if you : have heart problems , high blood pressure , tuberculosis ( tb ) of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much revinty ellipta to use asthma the recommended dose for asthma is one inhalation of fluticasone furoate 22 mg twice a day ( vilanterol ). for severe asthma , your doctor will prescribe the higher strength inhaler to deliver the full dose of the medicine . your doctor may prescribe the dose that is right for you . this is called the " maintenance dose ", which is based on your weight and the condition you are suffering from . the usual dose for flutic
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate breathing problems while taking revinty ellipta your
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 microlitres ( 6 . 6 mg / m2 ). - the delivered dose is as follows : - a daily dose ( maintenance dose ) for adults and children of 92 years of age and older , the dose depends on the weight of the child at the time of the inhalation and the dose that the child is taking . - the other ingredients are : - tablet core : lactose monohydrate
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine ( also known as a nucleosidermal necrolysis ( nrti ) and tenofovir ( a nucleotide reverse transcriptase inhibitor ). these active substances belong to a group of antiretroviral medicines , which work by interfering with the normal working of an enzyme ( reverse translcriptase ) that is essential for the virus to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects , such as dizziness and drowsiness , have been reported . if you take more tablets than you should if you accidentally take too many tablets , contact your doctor straight away . if possible , show the doctor your pack of tablets . you may need to take other medicines to control your hiv infection . if
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) may occur rarely ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor
what atripla contains ∑ the active substances are efavirenz , emtricitabine and tenofovir disoproxil . ∑ eachatripla film - coated tablet contains 600 mg of the three active substances , ∑ eflavirenz and 200 mg of emtripitalabine , respectively 245 mg of ten ofovirdisoproxel ( as fumarate ). ∑ tablet coating : croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate (
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin , which are produced by recombinant dna technology without addition of any human - or animal - derived components in the manufacturing process . it is produced by biotechnology in the laboratory of a company called gnrh and belongs to the class of medicines called follicle stimulating hormone ( fhh ) and is used for the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells and are used to release the immature egg cells
do not use orgalutran : if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gnrh analogue . if you have a moderate or severe kidney or liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before using this medicine . warnings and precautions if you develop signs of an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions allergic reactions are general
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran will only be given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ) on day 2 or day 3 of each cycle . your doctor will give you a single injection of either one or more of the components of the preparation . each injection will be given under the skin ( subcutaneously ) over a period of 5 to
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect very common ( may affect more than 1 in 10 people ) local skin reactions ( e . g . redness and swelling ). if the local reaction is severe , it usually disappears in about 4 to 1 in 100 people . headache , nausea , malaise ( rare ) may occur ( very rare ) but may be life - threatening ( frequency cannot be estimated from the available data ) allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). syringes should be clear , liquid - free solutions and should not be re - used .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ) and water for injections ( for the ph ). - the solvent is sodium hydroxide ( see section 2 " important information for the pharmacist " for further information ). - each ampoule contains a minimum of 4 ampoules , each corresponding to a concentration of 1 ml / ml of solution for subcutaneous administration . the needle is contained in a clear , dry natural rubber / latex . - each pack of
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte " ( b lymphocytes ). how blitzima works blitzima can be used to treat : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that is part of the immune system ) in adults . it reduces the number of an abnormal type of a white blood type called b- lymphocytes . using blitzima in combination with
do not use blitzima : if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before using blitzima if : you have ever had granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section " other medicines and blitz
your treatment with blitzima will be overseen by a doctor who is experienced in the use of this treatment . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may reduce your dose . blitzima is given as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be given blitzima in combination with other medicines ( pre - medication ) to reduce the risk of side effects . the duration of your treatment will depend on the type of non - hodgkin ' s lymphoma you
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . this medicine does not require any special temperature storage conditions . after dilution , chemical and physical in - use stability has been demonstrated for 8 hours at 25ºc . from a microbiological point of view , the product should be used immediately . once dilution has taken place in controlled and validated aseptic conditions , it must be used within 8 hours or disposed of . the product must not be re - used if it
what blitzima contains - the active substance is rituximab . each ml of solution contains 10 to 100 mg of the active substances . - each vial of powder for concentrate for solution for infusion contains 10 mg , 50 mg , 500 mg or more of ritukimab in 10 ml . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for injection or infusion . each pack contains 2 vials of 50 ml or 1 v
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a protein that recognises and attaches to a specific target in the body ). it blocks the activity of a protein called interleukin - 6 , which is involved in causing the inflammation in your body . when used in children and adolescents , it is used for the treatment of symptoms such as pain and swelling in your joints . your doctor has prescribed roactemrea to reduce the damage to the cartilage and bone in the joints caused by the disease . your child has moderate to severe active rheumatoid
do not use roactemra : if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor , nurse or pharmacist before using the infusion . you may be more likely to experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips , skin rash , or any other signs of infection . infections tell your doctor or nurse immediately if you feel unwell . your doctor may need to adjust your dose of ro
always use roactemra exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the intravenous infusion will be given to you by a doctor or nurse . the treatment will usually last about 8 hours . your doctor will decide how long you should be treated . the recommended dose is as follows : the usual starting dose is 8 mg once a day . this will be gradually increased over the next 4 hours . if you have the impression that the effect is too strong or too weak , talk to your doctor . how much to use the recommended daily dose is
like all medicines , roactemra can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity , which has been reported in at least 1 in 1000 people . tiredness , abdominal pain ,
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and on the label of the vial after exp . store in a refrigerator ( 2 8 ). do not freeze . this medicine does not require any special temperature storage conditions . the following information is intended for the specialist only : do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains - the active substance is tocilizumab . each ml of solution contains 4 mg of 80 mg of tociluzumab when reconstituted as recommended . each 20 ml vial contains 10 mg / ml of 200 mg ( as directed by your doctor ). - the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactoremra looks like and contents of the pack roactremra is a clear , colourless to pale yellow concentrate for solution
ibandhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . onbrez breezhaler is used to treat breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles , making it easier for air to get in and out of the lungs when you breathe in .
do not use onbrez breezhaler : if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before using onbrezer if you : have heart problems . have epilepsy . have thyroid gland problems ( thyrotoxicosis ). have diabetes . if any of these apply to you , tell your doctor or pharmacist immediately . if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these could be signs of a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 microgram once a day depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last inhaled it . how to use onbrez breezhaler you will find an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ) that you need to inhale . you can use the on
what onbrez breezhaler contains - the active substance is indacaterol . one capsule contains 150 international units ( iu ). - the other ingredients ( excipients ) are lactose and the capsule is made up of gelatin ( e904 ). - each one of the 300 iu capsules contains 300 international units [ iu ] ( e1203 ) ( e1521 ) ( i . e1403 )( e553b ) ( printing ink : shellacatedol femaleate ( e487 ) ( see end of this leaflet for further information on the use of this product ). -
clopidogrel hcs belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thromboindrombosis ). you and your doctor have been shown to work by : - reducing the number of clots ( thrombi ) that can form in hardened blood vessels ( arteries ), an event known as atherothromb
do not take clopidogrel hcs : if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are in any doubt at all ), tell your doctor or pharmacist . warnings and precautions the following apply to all of your medical conditions : you should not be taken on any other day if you think you may be at increased risk of bleeding :
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower dose ( up to 300 mg of the active substance in one day ), but you should not take more than the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 milligrams of clopilogrel ( as hydrochloride ). the other ingredients ( excipients ) are ( see section 2 ' clopide contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that are resistant to other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics called cephalosporins . if you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ) which has been associated with severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . warnings and precautions talk to your doctor , pharmacist or nurse before you are treated with fetcro
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how fetcroja is given it is given as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 hours . your doctor will decide how many treatments you need and how often you need to use it . how often and for how long your treatment will last you will be checked by your doctor to check that your infection is not getting worse . if you get any pain during the fetcroja infusion , your doctor may decide to give you another drip into your vein .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction , which may include sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ccfiderocol . - the other ingredients ( excipients ) are sucrose , sodium chloride and sodium hydroxide ( see section 2 ). what fetcroJA looks like and contents of the pack fetcroja is a white to off - white powder for concentrate for solution for infusion supplied in a glass vial . each carton contains 10 vials .
depocyte is used to treat a condition called lymphomatous meningitis in adults , adolescents and children aged one month and above , as well as lymphoma tumour cells that have spread beyond the membranes of the brain and spinal cord . depocyte works by blocking the growth and spread of lymphoma cancer cells .
do not use depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . you should not be given any dexamethasone tablets to treat unwanted effects . if your side effects do not improve or get worse , tell your
always use depocyte exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . for the treatment of cancer in the lumber sac , depocyte will be prepared and given to you by a healthcare professional . your doctor will calculate the correct dose of depocyte and will give you injections of 1 to 5 micrograms of dexamethasone in 5 ml . each depocyte dose will be monitored by your doctor to detect any side effects . depocyte should be administered at a temperature not above 22 and below 30 . before withdrawing depocyte from the vial , make sure that proper
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these side effects with you and will explain the risks and benefits of your treatment . the following side effects have been reported with depocyte : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 1 , 000 ) very small number of patients are likely to experience adverse events when depocyte is administered in combination with other chemotherapeutic agents . very common : may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte may be stored at room temperature ( up to 25 ) for a single period of up to 4 weeks . if depocyte is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless dilution has taken place in controlled and validated aseptic
what depocyte contains - the active substance is cytarabine . each millilitre of suspension contains 10 mg ciprolylphosphatidylcholine . each vial contains 50 milligrams ( millilitres ) ( milliliter ) of cytarbine . - the other ingredients ( excipients ) are cholesterol , triolein , dioleoylph phosphatidylecholine ( e339 ), dipalmitoyluphosphATidylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte
the active substance in bemrist breezhaler is indacaterol . it belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometasone furoate is one of the most commonly used in asthma patients . it is used in adults to reduce the swelling and irritation ( inflammation ) in the smaller airways , which can lead to breathing problems . corticosteroids can also reduce attacks of asthma . your doctor will tell you how to use bem
do not use bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have heart problems , have an irregular or fast heartbeat . have thyroid gland problems . have diabetes or high blood sugar . have seizures . have a low level of potassium in your blood . have severe liver problems or have tuberculosis ( tb ) of the lung . have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with a glass of water . you can take the medicine with or without food . it is important that you continue to use the medicine until your doctor tells you otherwise . if your asthma does not improve or your symptoms get worse , you should contact your doctor . how much to use your doctor will tell you exactly how many capsules to use and how often to use . how to inhale the medicine your doctor may tell you to use or to change
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( might affect up to 1 in 100 people ): swelling , usually of either the tongue or lips , face or throat ( sign of angioedema ). other side effects other possible side effects are listed below . very common : may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light and moisture . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler contains 125 micrograms / 62 . 5 microliters ( inhaled inhaled using a black product code ). - the following pack sizes are available : - the capsule content is composed of 150 microgram ( 3 . 5 milliliters ) of indiacaterol and 80 milligrams ( 5 . 3 milligram ) of mometsone furuate . - the mouthpiece of the inhaler is made up of 125 micro
the active substance of zyllt , clopidogrel , belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). you have been prescribed zylltan because you have an increased risk of bloodclots ( thrombi )forming in hardened blood vessels ( arteries ), a process known as atherost
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking zllt . warnings and precautions you should tell your doctor if you : - have a history of bleeding ( e . g . amedical condition that puts you at risk of internal bleeding )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may lower your dose to 300 mg once a day . your doctor will tell you how long you should continue treatment . the maximum recommended dose for patients aged 75 years
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' zllt contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what
lamivudine teva will be given to you by a doctor or nurse who is experienced in the use of medicines to treat long term ( chronic ) hepatitis b infection in adults and children aged 12 years and older and weighing at least 25 kg . lamivudrine teva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver , and so is very sensitive to the effects of it on the health of the people around you . long term
you must not be given lamivudine teva : - if you are allergic , or think you may be , or are planning to have a baby . warnings and precautions 28 talk to your doctor , pharmacist or nurse before you are given this medicine if : - you are breast - feeding ( see section 28 of this leaflet for more information ). - you have liver disease , such as hepatitis c . you are overweight . your doctor may want to do blood tests before you start your medication . see section 4 for further information . if you have not been treated before , you may not be fully protected against the effects of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you take it every day until your doctor tells you otherwise . your doctor will check whether your infection is getting worse and will tell you how long you should continue to take it . if you have any further questions on the use of this medicine , ask your doctor , pharmacist , or nurse . how long to take the tablet each day depends on how long it is since you last
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of lamivudine teva are related to other conditions linked to hepatitis b . the following side effects have been reported during therapy for ' hepatitis b ' in clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these may be signs of an increase in enzymes in the muscles . allergic reaction ( rare , may affect up to 1 in 1 , 000 people ): swelling of eyelids , face or lips ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamvudine . each film - coated tablet contains 100 mg of lamivu . - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and iron oxide red ( e 172 ), sunset yellow fcf ( e110 ) ( sunset yellow ) ( see " sunset yellow " on the edge of the tablet ). what
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms can include fatigue , weakness and shortness of breath . it is usually caused by the lack of the natural hormone erythropoietin ( a substance produced by your kidneys ). your doctor has given you nespo to encourage your bone marrow to produce more redblood cells ( e . g . darbepoetin alfa ). chronic renal failure ( symptomatic anaemia ) in patients with chronic renalfailure , kidney failure or kidney failure
do not use nespo : if you have high blood pressure or are taking other medicines . if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given neespo ( darbepoetin alfa ) or r - huepo . some patients who are already taking medicines for sickle cell anaemia have experienced epileptic fits ( seizures ). convulsions ( fits ). seizures have been reported in patients with liver disease . drugs used to treat anaemia may cause an allergy to latex . the needle
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight per day . if you are not sure about this , talk to your doctor or pharmacist . the dose may be increased or decreased depending on your condition . the doctor may increase your dose or decrease your dose to a single injection just under the skin or into a vein ( intravenous ). if your anaemia is not controlled , your doctor may give you nes
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) high blood pressure ( hypertension ) fluid retention ( oedema ) rare ( affects less than 1 to 100 users in 10 , 000 ) serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ), shortness of
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening of the vial , you may remove your vial from the refrigerator and allow it to reach room temperature ( up to 30 ) for a single period of up to 7 days , but do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what nespo contains - the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms . - the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic ( e1200 ), sodium chloride , polysorbate 80 and water for injections . the solvent is a clear , colourless to slightly pearly liquid and not cloudy . 1 ml solution for injection is available in packs containing 4 pre -
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine is used to reduce abnormal formation of new blood vessels in the eye . macugen is used in adults , adolescents and children under the age of 18 years . your doctor has prescribed this medicine for you because you have a condition that causes vision loss ( damage to a part of the retina called macula ). macula is the thin layer between the retina and the macula . macula helps to protect the eye from light . abnormal blood vessels grow in the retina , making it harder for the
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macugen . an infection or bleeding in the eye may occur after macugen injection . tell your doctor immediately if you experience one or more of the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . the injection may slow down or stop the
mugen will be given to you by a doctor or nurse who is experienced in giving injections of macugen . macugen is given as a single injection into your eye . it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of your eye ( the front part of the eye ). macugen may be given in combination with antibiotic eye drops . your doctor will clean your eye and give you some local anaesthetic ( numbing medicine ) to reduce any pain that you may have after the injection . if you are allergic to antibiotics eye drops , your doctor may give you antibiotic treatment to reduce
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ). the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . this medicine does not require any special storage conditions . the medicine should be used immediately after preparation .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib ( corresponding to 90 mg / ml ). - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -
palifermin belongs to a group of medicines called escherichia coli . palifermin works by blocking the growth of epithelial cells in the mouth and digestive tract , which are tissues that line the skin . by blocking these cells , the medicine helps to protect the mucous membranes from moisture and inflammation of the mouth . the most common side effect reported with kepivance is oral mucositis ( soreness , dryness or inflammationof the mouth ). this side effect occurs more often in patients receiving treatments for your blood cancer than in patients who have received chemotherapy , radiotherapy or autologoushematopoiet
do not use kepivance : - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children under 18 years of age because there is no information on its safety or efficacy in this age group . other medicines and kepacivance tell your doctor or pharmacist if you have been taking , have recently taken or might take any other medicines . this includes any medicines obtained without a prescription .
your doctor will decide how much kepivance you will receive and for how long . your doctor will calculate your body surface area ( surface area ) in square meters ( m² ) and will determine the dose you will be given . the usual dose of cancer treatment for adults is one 60 mg film - coated tablet . the recommended dose for your doctor is one kilogram of the tablet to be given as an intravenous injection into a vein . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood . digestive enzymes may be removed from the blood during treatment and
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see section 2 ). what kepvelance looks like and contents of the pack kepalivance is a white powder supplied in a glass vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cicagrelcet , which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , near the thyroid gland , that help to keep the body free of the excess of calcium ( hypercalcaemia ). it is also used : to treat secondary hyperparathyroidism in patients with serious kidney disease who are not benefiting from dialysis or who are unable to take waste products because they have high levels of the calcium in the
you must not be given cinacalcet accordpharma : - if you are allergic ( or to any of the other ingredients of this medicine ) or if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before you are given this medicine , as your blood calcium levels may need to be monitored by your doctor . if you think any of these apply to you ( or you are not sure ), ask your doctor , pharmacist or nurse for advice . before your first dose , you should tell your doctor if : you have ever had seizures ( fits or convulsions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of cinacalcet accordpharma is one tablet a day . your doctor will tell you how many tablets to take and how long you should continue to take them . the tablets should be taken orally with or without food . regular blood samples will be taken during treatment to help determine the correct dose for you . if you have secondary hyperparathyroidism , your doctor may prescribe a lower or lower dose . the usual starting dose is one 30 mg tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches , cramps or seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . these side effects are usually mild to moderate and generally go away within a few days to a few weeks . common
what cinacalcet accordpharma contains each film - coated tablet contains either : 30 mg , 60 mg or 90 mg film - coating ( as hydrochloride ). the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose ( e464 ), titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ) ( only in the tablet coating ). see the end of this leaflet for further information about some of the ingredients . what the tablets look like and contents of
jentadueto contains two different active substances called linagliptin and metformin . both of these active substances are made in the body called dipeptidyl peptidase - 4 inhibitors , and belong to a group of medicines called metuanides . they work together to reduce blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or in combination with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflozin )
do not take jentadueto if : you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). you have severely reduced kidney function . you have uncontrolled diabetes with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . lactic acidosis ( see section " warnings and precautions "). this is the most common form of lacticacidosis . ketoacidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should only be prescribed to you by a doctor who is experienced in the treatment of patients who are currently taking metformin . individual tablets containing linagliptin and metforma should be taken at the same time each day . you should continue taking this medicine until your doctor tells you otherwise . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor . to reduce the chance of an upset stomach , take 5 mg lin
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion ( hypocaemia is a very rare , may affect up to 1 in 10 , 000 people ), but very serious side effect called lactic acidosis ( see section " warnings and precautions "). stop taking the combination jent
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . this medicinal product does not require any special temperature storage conditions . store in the original package in order to protect from moisture . this medicine should not be used if you notice any visible signs of tampering .
the active substances are linagliptin and metformin hydrochloride . each jentadueto 2 . 5 mg / 850 mg film - coated tablet contains two million international units ( iu ) per kilogram of body weight , corresponding to a daily dose ( equivalent to 1 , 000 international units ) of the iu / 800 micrograms iu group . the other ingredients are aspartame , propovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol .
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by preventing hiv from multiplying and infecting other people who are infected by hiv . it is used in combination with other hiv treatments . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you think any of these apply to you , tell your doctor or pharmacist . do not give this medicine to children and adolescents under the age of 18 years . this includes any possible side effects not listed in this leaflet . take special care with the following medicines : - carbamazepine , oxcarbazepine or phenobarbital or phen
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults ( 18 years of age and older ) the recommended dose of edurant is 1 tablet of rifabutin per day . this is a medicine used to treat some bacterial infections . your doctor will tell you how long you should continue to take it . do not change your dose unless your doctor tells you to . it is important that you continue to follow the advice about diet and exercise given to you by your doctor , pharmacist or nurse . if you have the impression that the effect of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains - the active substance is rilpivirine . each film - coated tablet contains rilpaline hydrochloride ( equivalent to 25 mg / dl ). - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose ( e460 ) and magnesium stearate . tablet coating : the film - coating contains lactosemonohydrate , hypromellose 2910 , 6 cp , titanium dioxide ( e171 ), macrogol 3000
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines help to control the level of sugar in your blood when you have type 2 diabetes . people with type2 diabetes either don ' t make enough insulin to control their level of blood sugar levels , or their body is not able to use the insulin it produces effectively ( called a sulphonylurea ). your doctor may ask you to switch to a different type of diabetes medicine .
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . do not take avandamet if : you are allergic ( hypersensitive ) to rosiglitazone or metformin . you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking avandamanet if any of the following apply to you : you have been in close contact with someone who has had a heart attack or severe angina . you have ever had heart failure or have had
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). your doctor will tell you how many tablets you need to take . this dose will be gradually increased by 1 mg every 8 hours . the maximum dose should be increased by 4 mg every 4 hours . your doctor may also increase your daily dose of rosigslitazONE ( equivalentto 1000 mg of met formin ). this dose may be gradually reduced by
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions can occur during treatment with avandamanet . signs include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you notice any of these symptoms seek medical advice straight away . the following side effect has been reported with metformin in patients with severe kidney disease . symptoms of lactic acidosis include rapid breathing , cold stomach pain , nausea and vomiting . contact your doctor immediately if you experience these symptoms . the use of avand
your doctor , pharmacist or nurse knows how to store avandamet properly .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains either : one tablet ( 600 mg ) of the two active substances , as besilate tablets . - each tablet ( 1 , 000 mg ) is made up of two different substances , called oscondazone ( 500 mg ) and meetformin ( 2 , 600 mg ). the other ingredients are : tablet ( 800 mg ), called ocondazion ( 1000 mg ), as besildate tablets ; tablet ( 4 , 500 mg ), while oscundazone [ 1000 mg ],
clopidogrel mylan belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombo - occlusion ). you and your doctor have been shown to reduce the risk of a major stroke ( including heart attack ) and death . if you have any of the following , talk to your doctor or pharmacist before taking clop
do not take clopidogrel mylan 31 if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are in any doubt at all ), tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are taken : if you currently have or are likely to have a condition that puts you at risk of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower dose , which may be up to 300 mg once a day . then , your doctor will give you another 300 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel mylan contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopilogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 for further information on the ingredients ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ], talc and
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) in adults , adolescents and children ( 12 years of age and older ) with a condition called thromboocytopenia . it is used in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and stop bleeding .
do not use doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have or have had blood clots in the veins or arteries . this is because it may increase the risk of bloodclots forming ( for example , if you have cancer ). - you are taking the contraceptive birth control pill or hormone replacement therapy . - you recently had surgery or are seriously injured . 23 you are overweight . you have advanced chronic liver disease .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose based on the results of your procedure . the usual starting dose is one 5 mg tablet once a day for up to 8 weeks . if you take more doptelet than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . you may need to take the tablets with or without food . the doctor will tell you how many tablets to take and how often you should take them . the maximum recommended daily dose of dopte
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( likely to affect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains an active substance called avatriocompag maleate . each tablet contains 20 mg / dl ( 23 . 5 mg / l ). - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . tablet coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles in the heart . rapiscan is used in adults to perform a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a machine that scans the muscles of the heart using a readmill to measure blood flow . a scan can only be done if you have a small amount of radioactive material in your body . it is given into a vein by your hand .
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or if you are using a pacemaker . if you experience chest pain ( unstable angina ), stop treatment and tell your doctor straight away if you suffer from low blood pressure ( hypotension ), heart failure or allergic to regadenoson . children and adolescents do not give this medicine to children under 6 years of age because it has not been studied in this age group . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if any of the following apply to you : if
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of approximately 400 minutes . the recommended dose is a 5 ml solution the injection will take about 5 to 10 minutes . depending on your weight , your doctor may give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( injection ) for 5 minutes . this medicine contains a radioactive substance ( radiopharmaceutical ). the dose of rapiscan you will receive will depend on your heart rate
like all medicines , rapiscan can cause side effects , although not everybody gets them . most of the side effects are mild to moderate . however , some may be serious and require the rapid injection of 30 minutes or any treatment . tell your doctor straight away if you notice any of the following side effects : sudden stopping of the heart , which may be signs of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face , and inability to speak . if any of these happen , stop taking rapisc
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . taking viagra is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain ") in adults . if you are not sure , talk to your doctor or pharmacist before taking the medicines . you are also taking nitric oxide donors such as amyl nitrite , which can also lead , or have been prescribed for you , by your doctor , to reduce the risk of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 50 mg tablet once a day . viagra film - coated tablets can be taken with or without food . do not take viagra orodispersible tablets . swallow the tablet whole with a glass of water . if you take more viagra than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . if possible , show them the pack of viagra . you may find it easier to get an erection when you are sexually stimulated
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious . stop taking viagra and see a doctor straight away if you notice any of the following serious side effects : viagra may cause an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . chest pains may occur if you are in a semi - sitting position . you may need to take nitrates to relieve your chest pain . prolonged and sometimes painful erections (
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinson '. it is also used to relieve the symptoms in adults with moderate to severe primary restless legs syndrome .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you think any of these apply to you , or if you have any medical conditions or symptoms , please tell your doctor . kidney disease may cause hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose of sifrol for the treatment of parkinson ' s disease is 3 tablets per day . during the first week , the usual starting dose is 1 tablet ( 0 . 088 mg ) once a day . this will be increased to a daily dose of 0 . 264 mg in the second week . your doctor may increase your dose to 1 tablet each day , until your doctor tells you otherwise . if your symptoms return , your doctor will tell you to take a lower dose . the
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( likely to affect 1 to 10 in 100 people ) rare : may affect up to 1 in 1 , 000 people not known ( frequency cannot be estimated from the available data ) very rare ( likely not to affect less than one in 10 , 000 patients ) with parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ) - dizziness -
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg or 0 . 35 mg , corresponding to a concentration of 0 . 7 mg / m2 . - the other ingredients are : tablet core : aminotransferase ( e1201 ), pregelatinised maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate ( e470b ). tablet coating : mannitol ( e421 ), maize starch ( e460i ), talc ( e553b ), anhyd
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . it is used in adults to prevent allergic conditions from occurring in the eye . the allergic reaction may be severe and may be life - threatening . the most common signs of allergic conjutivitis are itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor as soon as possible . you may feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist , or nurse before using this medicine . children and adolescents do not give this medicine to children or adolescents below the age of 3 years because benzalkonium chloride is present in the blood ( see also section 6 ). this medicine has not been shown in clinical trials with other eye drops . if any of these apply to you , tell your doctor or pharmacist . use in children under 3 years of age there is no
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is 3 drops in your eye once a day . this medicine is for use in both eyes . use in children and adolescents the recommended starting dose is 1 drop in the affected eye each day ( see section 2 ' how to use emadine '). follow your doctor ' s instructions for use . do not change the dose unless your doctor tells you to . if you have the impression that the effect of the medicine is too strong or too weak
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the following : common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness ( uncommon side effects ) effects affecting the lower part of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornea staining , dry eye . general side effects : headache , difficulty sleeping , sinus headache , bad taste , rash .
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . this will help protect you from infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose ( e464 ), purified water , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ) and water for injections ( see section 2 ). what emADine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to reduce the number of seizures in epilepsy ) in adults and adolescents 16 years of age and older . it is used for the treatment of newly diagnosed epilepsy , a form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). the epilepsy fits initially affect only one side of the brain , but can thereafter extend to larger areas on both sides of your brain . partial onset seizure ( with or without secondary generalisation ) has been reported in children and adolescents of all ages and has not been previously reported in adults . levetir
you must not be given levetiracetam actavis : if you are allergic to any of the active substances ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - are breast - feeding . - have kidney problems . - notice any slow down in the growth or unexpected puberty development of your child . - are taking anti - epileptics . if you think any of these apply to you , tell your doctor or pharmacist as soon as possible . do not give this medicine to children under the age of 16 years . other medicines and le
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis should be taken once a day in the morning and once in the evening , at about the same time each day . monotherapy dose in adults and adolescents from 16 years of age and older : the usual starting dose is 1 , 000 mg twice a day . your doctor may increase your dose up to a maximum of 3 times a day depending on how you respond to the medicine . the doctor will tell you how many tablets you need to take . if you have the impression
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms with a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests . reduction in a type of white blood cell 56 (
what levetiracetam actavis contains - the active substance is levetviracetam . each tablet contains either levetiraacetam as 250 mg or 250 mg of levetmiracetam ( as 500 mg film - coated tablets ). the tablet may be divided into equal doses . - the other ingredients are : tablet core : e464 ( e1201 ), e463 ( e464 ), e487 ( e553b ), e551b . tablet coating : e507b , e463b , dna2b , cdna3b , povidone , silica colloidal anhyd
the active substance umeclidinium bromide belongs to a class of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become damaged and difficult to breathe . this can lead to breathing difficulties , difficulties in breathing and tightening of the muscles around your airways . this medicine blocks the tightening of these muscles , making it easier for air to get in and out of the lungs . this helps to control your breathing difficulties and reduces the effects of copd on your
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have asthma . this medicine is not recommended in patients with asthma . your doctor may need to adjust your dose if you have heart problems . - have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - have severe liver problems . immediate breathing difficulties such as tight
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . if you use more incruse ellipta than you should if you think you may have inhaled too much of this medicine , talk to a doctor or go to a hospital straight away . symptoms of using this medicine may include a sudden attack of breathlessness or wheezing . to control this attack you may use a quick - acting
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may occur uncommonly ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while being treated with incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects these may affect more than 1 in 10 people : faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead . these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the sealed tray in the outer carton in order to protect from light . after first opening of the vial , the seal may be removed for a single period of up to 6 months . once the seal has been removed from the sealed tray , the product must be used within 6 months or discarded . if the seal is damaged , do not remove the
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms ( 0 . 5 millilitres ) umecylidium . each patient should receive a dose ranging from one to two doses ( equivalent to a daily dose of 65 microgram s ) of umelidatinium ( as mesbromide ). - the other ingredients are lactose monohydrate ( see section 2 under ' important information about lactose '), magnesium stearate ( e470b ) and water for injections . what inc
nucala contains the active substance mepolizumab , which is a monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( an important type of white blood cell that helps the airways to open ) and can affect the lungs . this can be very serious or life - threatening . how nucala works when used for the treatment of severe asthma , your doctor may prescribe medicines called high dose inhalers
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to reduce the dose to control their asthma . if you think any of these apply to you , tell your doctor or pharmacist as soon as possible . your doctor will decide if you need to stop or discontinue treatment . allergic and injection site reactions medicines of this type ( monoclonal
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week ( 1 injection in the pre - filled pen ). if you have any further questions on the use of nucala , ask your doctor , pharmacist or nurse . duration of treatment your doctor will tell you how long you should continue to receive the treatment . your doctor may decide to reduce your dose or stop the treatment temporarily , depending on your asthma symptoms and on how you respond to attacks . it is important that you continue to follow your doctor ' s instructions
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( this may be due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the other side effects listed above . very
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the label of the pre - filled pen after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pen in the outer carton in order to protect from light . after first opening , the pen may be stored for a single period of up to 7 days without being refrigerated again . after this period , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and
what nucala contains - the active substance is mepolizumab . each vial of 1 ml contains 100 mg of the medicine . - the other ingredients ( excipients ) are : sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucal 1 ml solution for injection is supplied as a pack containing 1 vial or as a multipack containing 3 vials or 1 multipack . not all pack sizes
what ninlaro is and what it is used for it is a cancer medicine that contains the active substance ixazomib . it is called a ' proteasome inhibitor '. what is it used for ? what is myeloma ? your doctor has prescribed this medicine for you because you have a cancer of the bone marrow called multiple myelo . it works by blocking the activity of a protein called " proteasomes ". how does it work ? when a person is given a medicine to treat multiple myoma , it may slow down or stop cell survival . how does this medicine work ? in most people , myel
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you ( or you are not sure ), do not take the tablet and contact your doctor immediately . if you have any further questions on the use of the product , ask your doctor or pharmacist . do not give this medicine to children or adolescents under the age of 18 years . there are no known cases of nerve problems such as tingling , numb
do not take ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many capsules of this medicine to take . do not take more than the recommended dose of one capsule twice a day . if you take more of the active substance in this medicine than you should : lenalidomide and dexamethasone once a day for 4 - week . you can take one of the following capsules : one of each capsule : one capsule of ninl
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs orfeet ( peripheral oedema ) skin rash ( itchy all over the body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps ( sweet
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after " exp ". do not store above 30 . store in the original package in order to protect from moisture . the capsule can be removed from the blister and left at room temperature ( up to 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg ixasomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ). printing ink : shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the printing ink contains : - the capsule content is white to off - white , printed with ' ix ' on one side and '
do not use palforzia : if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children aged 4 months to 17 years because treatment with peanut allergy may not be suitable for them . peanut ( desensitisation ) has not been studied in this age group . therefore , it is recommended that you contact your doctor or the nearest hospital immediately if you experience any of the following allergic reactions after you have been given palfORzia . food allergies may occur
do not take palforzia : if you are allergic to peanut or soya if you have severe asthma if your asthma is getting worse or you have a problem swallowing . if you suffer from long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . it may take up to 60 days before you feel better . talk to your doctor , pharmacist or nurse before you start treatment . if any of the above applies to you ( or you are not sure ), tell your doctor or pharmacist before you take the medicine . do not increase the dose of p
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been told by your doctor that you have allergy , allergic reactions ( anaphylaxis ) to palforzia or any of the other ingredients of this medicine ( listed in section 6 ). your doctor will discuss with you the potential risks and benefits of taking this medicine with you . initial doseescalation and up - dosing steps you should follow the instructions of your doctor , pharmacist or nurse regarding the initiation of these treatment steps . your doctor may instruct you to take the initial
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions tell your doctor straight away if you have any of the following symptoms during treatment with this medicine : - trouble breathing - throat tightness - feeling offulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palfORzia may cause problems with the stomach and digestive system ( eosinophilic oesophag
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp : do not store above 25 . store in the original package in order to protect from light . this medicine must not be used if you notice any hard lumps of powder or if the solution is discoloured .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg , 10 mg and 20 mg . the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palfORzia 100 mg oral powder in capsules with opening microstalline crosculose ( e460 ), colloidal Anhydrous sulphica ( e463 ) and magnesium unstearate ppd 300 mg oralpowder in sachet micromolecularly polysaturated ( e1203 )- derived from maize starch - derived from wheat - derived maize starch
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used to treat sleeping problems in adults . the duration of treatment is one month . your doctor will decide how long you should continue treatment . if you have problems sleeping , talk to your doctor .
you must not be given zerene : - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - when you are being treated for zerenea sleep apnoea syndrome , which may occur for short periods . - in patients with severe kidney or liver problems ( myasthenia gravis ). tell your doctor if you feel very weak , tired muscles , severe breathing or chest problems . children and adolescents do not give this medicine
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , do not take more capsules than your doctor tells you to . elderly ( over 65 years of age ) mild to moderate liver problems if you weigh less than 65 kg , your doctor may increase your dose to 5 mg once a day depending on how you respond to treatment . if the capsule is cloudy , you may experience an overdose . you may also feel increasingly drowsy
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very rare ( affects less than 1 users in 1 , 000 ) very rare : very rare rare : may affect up to 1 in 10 , 000 not known : frequency cannot been estimated from available data . very rare
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : tablet core : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate . tablet coating : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( e171 ). printing ink : shellac , lecithin , simethicone ( e1520 ), yellow iron oxide ( e172 ). what zereNE looks like and contents of the pack zeren 5 mg is an intense dark blue powder with
